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Exercise stimulus can be defined as endothelial wall shear stress. In the endothelial 
cells, the nuclear factor–kappa B (NF-κB) is an important intracellular signaling molecule 
by which changes in wall shear stress, sensed by mechanosensors, are transduced into the 
nucleus to initiate downstream eNOS gene expression. Recently, a polymorphism in the 
promoter region of the gene encoding a p50/p105 NF-κB subunit, NFKB1, has been 
identified. The NFKB1 ATTG insertion (I) / deletion (D) (NFKB1 I/D) promoter 
polymorphism transcriptionally regulates NFKB1 gene expression. However, the 
functional significance of this polymorphism has not been elucidated in endothelial cells 
under LSS and in endothelial function in humans. 
Therefore, the purpose of this study was to investigate whether the NFKB1 I/D 
promoter polymorphism had functional genetic properties in human umbilical vein 
endothelial cells (HUVECs) under physiological levels of unidirectional laminar shear 
stress (LSS), and further, whether the polymorphism was associated with changes in 
endothelial function after endurance exercise training in pre- and stage I hypertensive 
individuals. 
The major findings of the present study were that 1) a protein present in HUVECs 
preferentially and specifically binds to the I allele promoter compare to the D allele; 2) 
the I allele had significantly higher promoter activity than the D allele; and accordingly, 
the II homozygote cells had higher p50/p105 NFKB1 protein levels than the DD 
homozygote cells; 3) the II homozygote cells showed a greater increase in eNOS protein 
levels than the DD homozygote cells under unidirectional LSS; and 4) the I-allele carrier 
group had a greater reactive hyperemic forearm blood flow response, a measure of 
endothelial function, before exercise training; however, the NFKB1 I/D polymorphism 
was not significantly associated with the differential changes in endothelial function 
following exercise training. 
These results have potential clinical implications for endothelial dysfunction that are 
related to the development and progression of atherosclerosis and cardiovascular disease. 
In addition, our findings provide insight into the molecular mechanisms involved in the 
intracellular signaling transduction process of eNOS gene expression and function of the 
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The endothelium is a monolayer of epithelial cells lining the innersurface of all of the 
blood vessels in the body. At the interface between circulating blood and tissues, these 
cells function as a protective biological barrier and also as a fine sieve to regulate 
selective passage of macro- and gaseous molecules in and out of the circulating blood. In 
addition, the endothelial cells release a number of autocrine and paracrine substances50, 
126. Because of its strategic location, the endothelial cells readily sense changes in 
hemodynamic forces5, 131 and blood borne signals53, and respond by releasing a number 
of vasoactive substances (i.e. nitric oxide (NO)50, 126) and by initiating expression of the 
downstream genes such as endothelial nitric oxide synthase (eNOS) gene 5, 79, 131, 191. 
Over the last two decades, function of the vascular endothelium has emerged as a 
strong marker for monitoring cardiovascular (CV) health on the basis that impairment of 
endothelial function is the earliest event in the process of developing atherosclerosis110. 
Endothelial dysfunction has been frequently associated with all common CV risk factors 
predisposing to atherosclerosis, such as age19, 37, 174, 190, obesity170,  post-menopause173, 
hypertension108, 143-145, 176, hypercholesterolemia16, 28, 69, diabetes119, 120, 185, smoking18, 69, 
and physical inactivity48. 
In the presence of endothelial dysfunction, improvement in the endothelial function 
has been observed with various pharmacological treatments9, 75, 77, 86, 158, and also was 
evident with behavioral modifications43, 159 including increased physical activity48, 56, 102, 
172.  
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Therefore, investigation of the mechanisms underlying the salutary effect of physical 
activity and its related stimulation on endothelial function has an important clinical 
significance. 
 
Endothelial nitric oxide synthase 
NO is a well-known endothelium-derived, atheroprotective, vasodilatory, and anti-
proliferative molecule which maintains vascular integrity and regulates endothelial 
function50, 141. The classical endothelium-derived relaxing factor, NO, is synthesized by a 
reaction converting L-arginine to L-citruline, a reaction catalyzed by eNOS50, 140, 141.  
L-arginine-based inhibitors of eNOS increase blood or perfusion pressure and 
vascular resistance and reduce blood flow in vivo76, 152 and in vitro155. eNOS knockout 
mice (-/-) are mildly hypertensive relative to wild-type littermate control mice (+/+). 
Moreover, the suppressor effect of an eNOS inhibitor is attenuated in the -/- mice and 
endothelium-dependent relaxation in response to acetylcholine is abrogated in the 
isolated vessels83, 166. 
eNOS is constitutively expressed in endothelial cells131, but it is also subjected to a 
modest degree of regulation in certain conditions. In vitro, eNOS expression is increased 
by shear stress131, cyclic strain5, exposure to lyshosphatidylcholine191, low concentrations 
of oxidized low density lipoprotein (LDL)79, and cyclic GMP analogues151. In vivo, the 
most important physiological agonist for NO release is fluid shear stress.  
eNOS posttranslational modification/activation occurs via calcium/calmodulin-
dependent and independent mechanisms49, 163, 164. Flow shear stress induces eNOS 
activation and NO release by recruitment of upstream kinases11, 35, 45, 123  
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Under basal conditions, systemic NO production and bioavailability is diminished in 
patients with cardiovascular diseases, and the impaired NO release may play a role in 
pathogenesis of hypertension and atherosclerosis47, 111. 
Thus, the shear-mediated regulation of eNOS gene expression is an important issue 
related to NO bioavailability to maintain endothelial function in pathophysiologic 
conditions.  
 
Hemodynamic shear stress and mechanotransduction: Regulation of eNOS gene 
expression 
Vascular endothelial cells are constantly exposed to hemodynamic shear stress. The 
magnitude and pattern of the shear stress vary depending mainly on the level of local 
blood flow and vascular geometry, which varies by location in the vascular tree.  
The regions of arterial narrowing or extreme curvature, where low-velocity and 
oscillatory flow is frequently observed, have a predilection for atherosclerotic lesions. In 
contrast, the straight regions of the vascular tree where unidirectional laminar flow is 
dominant, are generally atheroprotective113. Based on in vitro studies, unidirectional 
laminar shear stress (LSS) greater than 15 dyne /cm2 is associated with upregulation of 
vasoprotective endothelial genes (i.e. eNOS gene) which have anti-inflammatory, 
antioxidant, anti-apoptotic, and anti-proliferative properties. 
LSS activates the inhibitor kappa B kinase α subunit (IKKα) via the c-Src and MEK 
1/2 dependent signaling pathway, increases proteosome-dependent degradation of 
inhibitor kappa B alpha subunit, and induces nuclear translocation of the p50/p65 NF-κB 
complex10, 31-33, 60, 67. The NF-κB complex binds to the shear stress response element at 
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position -982 in the human eNOS gene promoter resulting in increased gene expression33. 
Moreover, inhibition of the NF-κB -mediated signaling completely blocks the increase in 
eNOS transcription in endothelial cells exposed to the shear stress60. Accordingly, the 
p50/p65 NF-κB complex is an essential transcription factor in the response of eNOS gene 
expression to LSS in endothelial cells.  
 
Exercise, endothelial function, and heritability 
At the cellular level, exercise acts as a physiological stressor that disturbs resting 
homeostasis. In the vasculature, the exercise stimulus can be defined as endothelial wall 
shear stress. During exercise, flow velocities are approximately double those observed 
during rest, and flow reversal and regions of the low velocity/oscillatory shear stress that 
existed under resting condition are eliminated24, 127, 178. Independent of reducing CV risk 
factors, the increased flow-mediated shear stress during exercise plays a significant role 
in the improvement of endothelial function with physical activity50, 101, 130, 165, 189. 
Exercise intervention studies have shown that exercise training improves endothelial 
function in both healthy94, 100, 169 and diseased76, 102 individuals. Animal studies have 
shown that endurance aerobic exercise training increased eNOS protein content in 
coronary and small resistance arteries34, 101. In addition, the application of physiological 
levels of unidirectional LSS increased eNOS mRNA and protein levels in endothelial 
cells in vitro150, 189. Taken together, enhancement of the eNOS gene expression and 
activation seems to play a significant role in the beneficial effect of exercise on the 
endothelium. 
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A number of studies have proposed a modest contribution of genetic factors to the 
variability in blood pressure and endothelial function3, 8, 184. Also several studies have 
shown that a positive family history of CV diseases is an important predictor of impaired 
endothelial cell function25, 51, 160. In addition, it has been proposed that genetic factors 
may be involved in determining the direction and magnitude of the beneficial 
cardiovascular adaptations that occur with exercise training in individuals with CV risk 
factors63, 109, 186. 
 
Nuclear factor kappa B and the p50/p105 NFKB1 gene 
NF-κB is a ubiquitous dimeric transcription factor that regulates expression of 
various genes related to inflammation, cell adhesion, cell division, apoptosis, and stress 
responses52. There are five members of the NF-κB family in mammals: p50/p105, 
p65/RelA, c-Rel, RelB, and p52/p100. Although many dimeric forms of NF-κB have 
been detected, the major inducible form of NF-κB is a heterodimer of the p50 and p65 
subunits21.  
In a quiescent cell, the NF-κB complex is retained in the cytoplasm by binding to a 
protein inhibitor, inhibitor kappa B (IκB)7. The formation of the NF-κB/IκB complex 
masks a critical nuclear localization domain (NLD) on a conserved N-terminal region of 
NF-κB proteins, called the Rel homology domain, and this prevents the translocation of 
NF-κB dimers into the nucleus. Once the cell is stimulated by appropriate stimuli, IκB 
kinase (IKK) phosphorylates the IκB complex at Ser32 and Ser36 on the IκBα subunit 
followed by ubiquitination and proteosome-dependent degradation of the IκB complex2, 6. 
Dissociation of IκB from NF-κB exposes the NLD of the NF-κB complex, so that the 
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NF-κB complex is translocated into the nucleus and binds to a κB-binding site on a target 
gene to initiate gene transcription7.  
The human NFKB1 gene has been localized to 4q23-q24. It encodes two proteins, a 
105 kilodalton (kDa) non DNA-binding cytoplasmic molecule (p105) and a 50 kDa 
DNA-binding protein (p50) that corresponds to the N terminus of p10571. Recently, a 
functional promoter polymorphism, NFKB1 ATTG insertion (I) / deletion (D) (NFKB1 
I/D) promoter polymorphism, has been described91. The polymorphism is located 
between transcription factor binding sites for AP-1 and κB in the promoter region. The 
allele frequencies of NFKB1 I and NFKB1 D allele in the normal population are 
approximately 60% and 40%, respectively. The NFKB1 I/D promoter polymorphism has 
been shown to transcriptionally regulate NFKB1 gene expression in HT-29 and HeLa 
cells91. However, the functional significance of the polymorphism has not been 
elucidated in endothelial cells under flow shear stress. 
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PURPOSE OF THE STUDY 
 
Vascular endothelial function has emerged as a strong marker for monitoring 
cardiovascular health on the basis that the impairment of the endothelial function is the 
earliest event in the process of atherosclerosis. Nitric oxide is a key endothelium-derived 
relaxing factor and a strong atheroprotective substance, and it is generated by endothelial 
nitric oxide synthase (eNOS).  
As a systemic stressor, a bout of endurance exercise is translated into unidirectional 
laminar shear stress (LSS) in endothelial cells due to increased blood flow during 
exercise. There are several lines of evidence showing that LSS underlies the adaptations 
of the endothelium to chronic endurance exercise training. In addition, nuclear factor 
kappa B (NF-κB) is an important intracellular signaling molecule in endothelial cells by 
which changes in wall shear stress, sensed by mechanosensors, are transduced into the 
nucleus for downstream eNOS gene expression. Recently, a functional insertion (I) / 
deletion (D) polymorphism in the promoter region of the gene encoding a p50/p105 NF-
κB subunit, NFKB1, has been identified. However, the functional significance of the 
polymorphism has not been elucidated in endothelial cells under LSS and in endothelial 
function in humans. 
Therefore, the purpose of this study was to investigate whether the NFKB1 I/D 
promoter polymorphism has functional genetic properties in eNOS gene expression under 
physiological levels of unidirectional LSS in human endothelial cells, and further, 
whether the polymorphism is associated with endurance exercise training-induced 




The central hypothesis of this study is that the NFKB1 -94 ATTG insertion (I) / 
deletion (D) promoter polymorphism has functional properties in eNOS gene expression 
that respond to unidirectional laminar shear stress (LSS) in Human Umbilical Vein 
Endothelial Cells (HUVECs), and that the polymorphism is associated with differential 
changes in endothelial function after exercise training. The specific aims of this study are 
shown below. 
 
Hypothesis #1 (In vitro study) 
The NFKB1 I/D promoter polymorphism has functional genetic properties that 
respond to in vitro unidirectional LSS in HUVECs.  
 
Specific Aims 
1.1 Determine whether NF-κB-mediated signaling is induced by unidirectional LSS 
in HUVECs. 
1.2 Determine whether the NFKB1 I/D promoter polymorphism affects DNA-
protein binding activity between the polymorphic promoter region and nuclear 
proteins extracted from HUVECs. 
1.3 Determine whether the NFKB1 I/D promoter polymorphism affects 
transcriptional activity under unidirectional LSS in HUVECs. 
1.4 Determine whether the NFKB1 I/D promoter polymorphism affects intracellular 
levels of eNOS protein under unidirectional LSS in HUVECs. 
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Hypothesis #2 (In vivo study) 
The NFKB1 I/D polymorphism is associated with differential changes in endothelial 
function following exercise training. 
 
Specific Aims 
2.1 Determine whether the NFKB1 I/D polymorphism is associated with 
changes in peak forearm blood flow with endurance exercise training. 
2.2 Determine whether the NFKB1 I/D polymorphism is associated with 





Study Design Overview 
To address the hypotheses, a complementary study design including in vitro 
unidirectional laminar shear stress (LSS) experiments and an in vivo human exercise 
intervention study were conducted. <Figure 1>  
In the in vitro shear stress experiments, primary-cultured Human Umbilical Vein 
Endothelial Cells (HUVECs) from different donors allowed us to obtain cells with 
different genotypes (II, ID, and DD genotypes). In some experiments, heterozygote 
HUVECs were subjected to transient transfection with I-type or D-type promoter-reporter 
gene constructs to establish genetic models. The HUVECs growing on a gelatinized 
culture dish were exposed to physiological levels of unidirectional LSS generated by a 
cone-and-plate apparatus. The NFKB1 gene promoter activities and the protein 
expression levels were measured in the cells. Therefore, the in vitro shear stress 
experiments provided molecular genetic data which elucidated the function of NFKB1 
I/D promoter polymorphism on eNOS gene expression in HUVECs.  
In the in vivo human exercise intervention study, sedentary middle-aged to older Pre- 
and Stage I hypertensive men and women were recruited and screened for diseases or 
clinical conditions that may confound the data interpretation. The qualified subjects 
underwent a 6 week dietary stabilization period and those who were using 
antihypertensive medications were tapered from their medication. Subjects were 
genotyped for the NFKB1 I/D polymorphism and underwent 6 months of exercise 
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training. To assess the endothelial function, reactive hyperemic forearm blood flow were 
measured before and after the exercise training.  
 




















Figure 1. Complementary in vivo and in vitro Experimental Study Design 
 
Human hypertensive subjects and Screening 
Human Pre and Stage I hypertensive subjects were recruited to the project 
investigating the interaction between genetic factors and an exercise intervention on the 
regulation of blood pressure (BP). Men and women responding to media advertisements 
and fliers were contacted by telephone to assess their eligibility. All the protocols 
involved human subjects were approved by the Institutional Review Board of the 
University of Maryland, College Park (IRB no. 01075 and no. 00736; IRB HSR ID no. 
04-0319).  
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Subjects were sedentary (aerobic exercise <2 times/wk, <20 min/session, sedentary 
job); 50 - 75 yrs of age; nondiabetic; not on lipid-lowering medications; suspected of 
having Prehypertension or Stage 1 Hypertension (systolic BP: 120-159; diastolic BP: 80-
99); and have no evidence of chronic obstructive pulmonary disease. Subjects also would 
not have any other medical conditions precluding vigorous exercise. Subjects had to have 
a body mass index <37 kg/m2. Women were postmenopausal (absence of menses for >2 
yrs). Hypertensive subjects using more than one antihypertensive medication were 
excluded from participation. Women were excluded from further participation in the 
study if they changed their hormone replacement therapy regimen during the course of 
the study.  
Orientation Visit: Subjects visited our laboratory and had their medical history forms 
reviewed by the study physician to determine if they met any criteria that would exclude 
them from the study. The written informed consent form was signed by the qualified 
subjects and co-signed by principal investigators. 
Screening Visit #1: Subjects reported in the morning after an overnight fast of >12 
hours and blood samples were drawn for basic blood chemistries and deoxyribonucleic 
acid (DNA) analysis. After the baseline blood draw, subjects were instructed to drink 10 
fl oz of a glucose tolerance test beverage within two minutes. Another blood draw took 
place in 2 hours in order to measure 2 hour glucose level. Subjects were excluded if they 
had a hematocrit <35, serum creatinine >135 mmol/L, evidence of renal or liver disease, 
or fasting glucose >126 mg/dL.  
Screening Visit #2: Qualified subjects then underwent a maximal treadmill exercise 
test to screen for coronary heart disease, preceded by a physical examination by a 
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physician to screen for CV disease. BP and ECG was recorded before the test, at the end 
of every stage of the exercise, and every other minute for 6 minutes after exercise. The 
test was terminated when the subject could no longer continue or CV signs/symptoms 
occurred. Subjects who had > 2 mV ST-segment depression or CV signs/symptoms were 
excluded from the study.  
Diet Stabilization and Medication Withdrawal: Because differences in dietary intake 
between the subjects could independently affect some of the outcome variables, all 
subjects maintained the American Heart Association (AHA) Dietary Guidelines for 
Healthy American Adults, formerly called a “Step I” diet. Qualified subjects underwent 6 
wks of instruction in the principles of an AHA low-fat (< 30% total calorie intake) and < 
3 g/day sodium diet that maintained for the entire study period. This training consisted of 
2 sessions / week and was instructed by a research dietitian.  
Subjects on one antihypertensive medication began a tapering schedule 
recommended by their physician at the start of the Dietary Stabilization period. The study 
physician also supervised the medication tapering process. All subjects had their BP 
measured weekly. If a subject’s systolic or diastolic BP was >159 or >99 mm Hg, 
respectively, for 3 consecutive weeks at any time during the study, they were excluded 
from further participation in the study and referred back to their personal physician. 
 
Measurement of Casual Blood Pressure 
Casual BP was measured according to the seventh report of the Joint National 
Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure 
(JNC VII) guidelines. In brief, subjects fasted for more than 12 hours before the 
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measurement. Subjects rested in a seated position for 20 minutes and BP was measured at 
least two times until both systolic and diastolic BP values were within 4 mm Hg. For 
each day the casual BP was measured, all values that deviated by less than 4 mm Hg were 
averaged for both systolic and diastolic BP. The casual BP was calculated by averaging 
the average BPs obtained across all three days. 
 
Measurement of Maximal Oxygen Consumption 
All subjects underwent a second maximal treadmill exercise test to assess maximal 
oxygen consumption (VO2max) and to prescribe exercise training. This test was supervised 
by the study physician. This test started at 70% of the peak heart rate achieved on each 
subject during their screening exercise test of each subject and the treadmill grade was 
increased by 2% every 2 minutes. BP and ECG were monitored. The criteria for VO2max 
included a respiratory exchange ratio (RER) ≥ 1.15, failure of increasing oxygen 
consumption ≥ 2 ml/kg/min as the exercise intensity increased, and the subject could no 
longer continue to exercise. 
 
Measurement of Forearm Blood Flow During Reactive Hyperemia 
Forearm blood flow (FBF, ml·min-1·100ml-1 forearm tissue volume) was measured in 
the morning (7:00 ~ 9:00 am) after an overnight fast (12 hr) in the non-dominant arm 
using venous occlusion plethysmography method as described elsewhere.76, 134, 145 
Subjects were instructed to rest in the supine position for 20 minutes before the testing 
was performed. A strain gauge was placed around the widest part of the forearm, which 
was elevated slightly above the level of the right atrium. The strain gauge was connected 
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to a Hokanson EC-5R plethysmograph (Hokanson Inc, WA) calibrated to measure the 
change in forearm volume. For each measurement, a BP cuff placed around the upper 
arm was inflated to 55 mm Hg and connected to a rapid cuff inflator (E-20, Hokanson 
Inc) to occlude venous outflow from the extremity. A wrist cuff was inflated to 
suprasystolic pressure before each measurement to exclude the hand circulation from the 
measurement of FBF.  
 Baseline FBF were measured 3 times, each separated by 10-15 seconds. Reactive 
hyperemia was then induced by inflating the cuff on the upper arm to 50 mm Hg above 
the systolic BP for 5 minutes to occlude the FBF. Immediately after the cuff was released, 
FBF was measured for 3 minutes at 15 second intervals (7 sec measure + 8 sec recovery). 
BP was measured each minute during the reactive hyperemic period.  
Three parameters were obtained from the FBF curve during the procedure: peak 
FBF; minimum forearm vascular resistance (FVR) (mm Hg·ml-1·min-1·100ml-1), 
calculated from peak FBF and mean blood pressure (MBP) measured just after the 
release of the cuff; and duration of reactive hyperemia, defined as the interval (seconds) 
between the release of occlusion and the return to +5% of the baseline FBF. Furthermore, 
total hyperemic FBF was determined from the area under the FBF curve (AUC) during 
the period of recovery after release of occlusion. Reactive hyperemia variables were 
calculated as follows: flow debt (ml/100ml) = baseline FBF X duration of occlusion; 
excess flow (ml/100ml) = total hyperemia flow – (baseline FBF X duration of reactive 
hyperemia). Hyperemia repayment (%) was calculated a ratio of excess flow and debt 
flow. FBF was calculated by 2 independent observers unaware of the subjects’ profiles. 
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Endurance Aerobic Exercise Training Program 
After completing baseline testing, subjects underwent 3 supervised exercise sessions 
/ wk for 6 months. The exercise session included warm-up and stretching exercises and 
whole body dynamic aerobic exercise. Heart rate was used to monitor their training 
intensity. Initial exercise training consisted of 20 min 50% VO2max, and the training 
duration and intensity were gradually increased until 40 minutes of exercise at 70% of 
VO2max was completed. After 10 weeks, one day of walking exercise for 40 minutes was 
added to the exercise program.  Exercise modes included walk/jogging, stair stepping, 
and cycle, cross-country ski, and rowing ergometry. 
Each subject’s resting BP was monitored weekly throughout the exercise training 
intervention. The body weight was monitored throughout the study and subjects were 
instructed to maintain their body weight within ±5% of their initial body weight. 
 
Genotyping the NFKB1 and NOS3 Gene Polymorphisms 
A blood sample was drawn into 10mL EDTA tubes from an antecubital vein at the 
first screening visit. The anti-coagulated whole blood was centrifuged at 3,000 g for 20 
minute to separate a white buffy coat region. Genomic DNA was isolated using the 
Genomic DNA Purification Kit (Gentra Systems, MN). For HUVECs’ genomic DNA 
isolation, HUVECs grown in a 175cm2 culture flasks were harvested with 0.25% 
trypsin/EDTA. Cell pellets underwent a standard procedure provided by the Gentra 
PUREGENE DNA Purification kit (Gentra Systems, MN) for cells and tissues.   
Genotyping for the NFKB1 -94 insertion/deletion ATTG polymorphism was 
performed as described by Karban et al.91 by a combined polymerase chain reaction 
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(PCR)-restriction digestion method. Briefly, a 289 bp PCR fragment was amplified from 
genomic DNA using specific forward and reverse primers, F:5’-
TTCAGTTGTCACTCCACCCA-3’ and R:5’-CTCTGGCTTCCTAGCAGGG-3’. 
Products were digested by the enzyme Van 91I (new England BioLabs, Inc., MA), which 
cleaves the -94 insertion ATTG containing product twice and the -94deletion ATTG 
containing product once, and the fragment length was analyze on a 2.5% agarose gel. 
<Figure 2> Genotyping accuracy was confirmed with a direct sequencing.  
Based on recent finding of significant functional effect of the C allele in the T → C single 
nucleotide substitution at -786 of eNOS gene on shear stress insensibility17, the eNOS 
gene polymorphism was also screened to exclude CC homozygote HUVECs in the 
present study. Briefly, the flanking regions of NOS3 gene was amplified using a pair of 
primers, F: 5’-CACCCAGGCCCACCCCAACCT-3’ and R: 5’-
GCCGCAGGTCGACAGAGAGACT-3’through PCR. The PCR amplicon was digested 
overnight at 37ºC using Msp I (new England BioLabs, MA) followed by electrophoresis 
for 4 hours in a gel composed of 2% agarose + 1% Nusieve (FMC, ME). The T allele 
(absence of the Msp I restriction site) yields a fragment of 415 bp, and the C allele 





Figure 2. NFKB1 gene structure 
Diagram for genomic structure with the location of the 24 exons (top) and sequence of the -
740 bp 5’ of exon 1 through +245 (bottom) are shown. The -94 insertion/deletion ATTG 
polymorphism is indicated. Van91I restriction sites used for genotyping and AP-1, κB and 
HIP-1 DNA binding motifs are designated. (Modified from Karban et al. 200491) 
 
HUVECs and cell culture 
HUVECs were purchased from the Emory Skin Diseases Research Center, 
Department of Dermatology, Emory University School of Medicine. These HUVECs 
were isolated from umbilical veins obtained from area hospitals.  This tissue was viewed 
as discarded tissue. The protocol was approved by the Emory University IRB for the use 
of this randomly obtained, discarded tissue. They were collected in sterile specimen 
containers with no patient information included with the specimen. HUVECs were grown 
in special endothelial cell culture medium supplemented with 20% Fetal Bovine Serum 
(FBS), 16 U/mL heparin, 50 µg/mL endothelial growth supplement, 2 mmol/L glutamine, 
100 U/mL penicillin and 100 µg/mL streptomycin and cultured with 5% CO2 at 37 °C in 
dishes coated with 0.1% gelatin to assist cell adhesion. 
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Shear Stress Experiments 
The unidirectional LSS and oscillatory shear stress (OSS) experiments were 
performed as described by Grumbach et al.61 Confluent HUVECs grown in 100-mm 
tissue culture dishes were exposed to unidirectional LSS in the growth medium by 
rotating a Teflon cone (0.5° cone angle). To mimic unstable shear conditions in vivo, 
cells were exposed to OSS with directional changes of flow at 1 Hz cycle by rotating the 
cone back-and-forth using a stepping motor (Servo Motor, OH) controlled by a computer 
program (DC Motor Company, OH). The shear experiments were conducted in a 
humidified environment with 5% CO2 at 37°C. Based on previous in vitro studies, 
unidirectional LSS greater than 15 dyne /cm2 is associated with upregulation of 
atheroprotective genes (i.e. eNOS) and downregulation of proatherogenic genes113, 118; 
moreover, direct vascular models of the low shear stress or OSS regions have revealed 
shear values on the order of ± 5 dyne/cm2 compared with greater than 10 dyne/cm2 in the 
atheroprotective or LSS regions.90 Therefore, we set the level of the unidirectional LSS of 
+ 15 dyne/cm2 (1.5 N/m2; arterial or high shear stress level) and OSS of ± 5 dyne/cm2 for 
the appropriate physiological level of fluid shear stress. The duration varied depending on 
the hypothesis that was being addressed. 
 
Preparation of Cell Lysates 
Cell lysate samples were prepared using a standard procedure using a total protein 
extraction method. Briefly, after the fluid shear stress or lipopolysaccharide (LPS, 100 or 
500 ng/ml) stimulation, the culture dishes containing HUVECs with static and shear 
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conditions were immediately placed on ice and washed three times with 1 mL of ice-cold 
PBS buffer solution followed by 1 mL of total protein extraction solution (containing 1% 
1X Triton X-100). After 3 minutes incubation on ice, the solution containing total protein 
extracts was harvested by scraping. The samples were homogenized using an ultrasound 
sonicator and stored at -80ºC until used. 
 
Preparation of Nuclear and Cytoplasmic Extracts 
For the nuclear protein analysis, cytoplasmic and nuclear proteins were fractionated 
with the NE-PER Extraction reagent (PIERCE, IL). Briefly, HUVECs were washed three 
times using 1 ml cold PBS buffer solution and harvested by gently scraping with 1 ml 
ice-cold PBS using a cell lifter. The suspended cells were centrifuged at 500 x g for 2-3 
minutes at 4 ºC. Using a pipet, the supernatant was gently discarded, leaving the cell 
pellet as dry as possible. 200 µl of ice-cold CER I solution was added and the tube was 
vortexed vigorously for 15 seconds to fully resuspend the cell pellet and then the tube 
was incubated on ice for 10 minutes. Then, 11 µl of cold CER II solution was added to 
the tube and vortexed for 5 seconds on the highest setting and the tube was incubated on 
ice for 1 minute. After vortexing the tube again for 5 seconds on the highest setting, the 
tube was centrifuged for 5 minutes at maximum speed in a microcentrifuge (16,000 x g). 
The supernatant (cytoplasmic fraction) was immediately transferred into a clean pre-
chilled tube and placed on ice until storage, and 100 µl of ice-cold nuclear extraction 
reagent was added. Then, the tube was vortexed for 15 seconds and returned to ice every 
10 minutes for a total of 40 minutes. The nuclear extract was obtained by centrifuging the 
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tube at 16,000 x g for 10 minutes and the supernatant was immediately transferred to a 
pre-chilled tube and stored at -80 ºC until used.  
 
Plasmid Construction / DNA Cloning 
NFKB1 I or D promoter-luciferase gene constructs were generously donated by Dr. 
Steven Brant at Johns Hopkins University. The reporter constructs include the NFKB1 
gene genomic sequence from -736 to +245 having either insertion or deletion allele of the 
DNA sequence variation. Restriction analysis and complete DNA sequencing confirmed 
the orientation and integrity of each construct’s inserts. To monitor the NF-κB signaling 
pathway, a commercially available reporter gene system, The MercuryTM Pathway 
Profiling Systems (Clontech, CA) was utilized. This profiling system allows for 
monitoring of translocation of conventional p50/p65 NF-κB complex. In the Mercury 
profiling vector, the specific cis-acting –κB binding sequence is located upstream from 
TATA box (PTA), which is followed by a luciferase reporter gene (pNFkB-TA-Luc). The 
negative control vector used in this assay was pTA-Luc vector, which lacks the –κB 
binding sequence (pTA-Luc). For an internal control, the thymidine kinase promoter-
Renilla luciferase control vector (phRL-TK) (Promega, WI), which contains the herpes 
simplex virus thymidine kinase promoter and Renilla luciferase gene, was used in all 




HUVECs having ID genotype were transiently transfected with the plasmid 
constructs of either pGL3-NFKB1(I) / pGL3-NFKB1(D), or pTA-Luc / pNFκB-TA-Luc, 
respectively.  
Equal number of HUVECs (1 X 106 cells per dish) were plated in each 10 cm2 
culture dish between 18-24 hours before the transient transfection. Subconfluent (approx. 
70-80%) HUVEC cells cultured in 100-mm dishes were transiently co-transfected with 5 
µg of either pTA-Luc, pNFκB-TA-Luc, pGL3-NFKB1(I), or pGL3-NFKB1(D) reporter 
vector and 250 ng of the phRL-TK using 3 µl of FuGENE6 according to the 
manufacturer’s manuals (Roche Molecular Biochemicals, IN). The phRL-TK vector was 
used as an internal control for transfection efficiency. The concentrations of each vector 
were determined following a Qiagen purification procedure in parallel using a 
spectrophotometer. Before transfection assay was conducted, culture media was replaced 
by special transfection media, containing only minimum supplements that were 
previously optimized. 
 
Preparation of cell lysate and luciferase assay 
After exposure to static or shear conditions, the transfected HUVEC cells lysate was 
harvested using the Passive Lysis Buffer (PLB) (Promega, WI) as per manufacturer’s 
instructions. Briefly, HUVEC cells were washed twice with ice-cold PBS buffer and 600 
µl of PLB was added to each dish. Dishes were incubated at room temperature on a 
motorized orbital shaker for 20 minutes and cell lysates were harvested by scraping and 
stored at -80 ºC until used. A dual luciferase system (Promega, WI) was used for firefly 
and Renilla luciferase assays. 50 µl of LAR II reagent was predispensed into glass test 
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tube. 20 µl of cell lysate was carefully transferred into the LARII in the test tube then 
place the tube in the Tropix luminometer after mixed by pipetting 2 or 3 times. After the 
reading was completed 50 µl of Stop&Glo reagent was added and briefly mixed, then the 
tube was placed again in the luminometer. A luminometer was programmed to perform a 
2-second premeasurement delay, followed by a 20-second measurement period for each 
promoter assay. Firefly luciferase activities were normalized to Renilla luciferase activity 
as ‘relative luciferase activity’.  
 
Electrophoretic Mobility Shift Assay 
Nuclear protein extracts were obtained from HUVECs grown at 37 ºC with 5% CO2 
in M199 supplemented with 20% FBS, L-glutamine, heparin and penicillin/streptomycin. 
Each of the nuclear protein extracts was obtained using the NE-PER kit from Pierce (MI) 
as described above. Complementary single-stranded oligonucleotide probes were 
synthesized based on the NFKB1 promoter as below. 
Insertion (I) : TCCCCGACCATTGATTGGGCCCGGC 
Deletion (D) : TCCCCGACCATTGGGCCCGGC 
Deletion variant (D1) : gcgtTCCCCGACCATTGGGCCCGGC 
M1 : TCCCCGACCcagtATTGGGCCCGGC 
M2 : TCCCCGACCATTGcagtGGCCCGGC 
M3 : TCCCCGACCATTGAaTGGGCCCGGC 
 
The canonical NF-κB p50/p65 protein binding consensus sequence (5’-
AGTTGAGGGGACTTTCCCAGGC-3’) was used as control162. An additional 4-base 
overhang (gatc) was added at the 5’ ends of each oligonucleotide to optimize end-
labeling with 32P. Complimentary oligomers were allowed to anneal, and then 
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radioactively labeled with dATP [α-32P] and dCTP [α-32P] according to the method of 
Feinberg and Vogelstein.42 Following purification by Qiagen the labeled, double-stranded 
DNA oligomers were then incubated for 30 minutes with individual nuclear extracts at 
room temperature. Electrophoretic mobility shift assay (EMSA) was performed as 
previously described.149  
 
Western Blotting 
Aliquots of cell lysates (20 µg of protein each) were resolved on a 10% SDS-PAGE 
gel and transferred to a polyvinylidene difluoride membrane (Millipore). The membrane 
was incubated with a primary antibody overnight at 4 ºC, and then with a secondary 
antibody conjugated with alkaline phosphotase (for eNOS protein, 1 hour at room 
temperature) or horseradish peroxidase (for p50/p105 and p65, 1 hour at room 
temperature), which was detected by chemiluminescence. The intensities of 
immunoreactive bands in Western blots were analyzed using National Institutes of Health 
IMAGE Program (Scion Image Beta 4.02). The primary antibody included eNOS (BD 
Bioscience, NJ), p50/p105 (Cell Signaling Technology, MA), p65 (BD, NJ) and Actin 
antibody (Santa Cruz Biotechnology, CA) will be used for internal control.  
 
Statistical Analysis 
Each variable was plotted and analyzed for variances to identify missing values, 
outliers, normality and patterns of skewness in the distributions.  
Analysis of covariance (ANCOVA) with repeated measures was used to test for 
differences in reactive hyperemic FBF responses among genotype groups. ANCOVA was 
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also used to test for differences in reactive hyperemic parameters between resting and 
reactive hyperemic conditions, and also for difference in percent changes in peak FBF, 
minimum FVR and total AUC between the genotype groups (II and ID). Based on the 
results of previous studies, demographic (age, gender and ethnicity) and biological (body 
weight, MBP and body mass index) confounding factors were used as covariates in all 
FBF analyses. As no ethnicity*genotype or gender*genotype interactions were observed, 
these groups were combined for all the analyses. A total of 12 out of 996 ((47+36) X 12 
time points) FBF values were not obtained during testing. In order to calculate total AUC, 
the missing values in the reactive hyperemic FBF measures were replaced by estimated 
values using a modified interpolation method, in which the mean % change value from 
the previous time point to the next time point among the total population was used to 
calculate the missing value. If the 15 second time point was missed, the sample was 
excluded from the analysis. In the analysis of genotype effect on the % change in reactive 
hyperemic FBF response, Student’s t-tests were used to test if there were significant 
changes in subject characteristics between before and after exercise training. 
In the reporter gene expression analyses, Student’s t-tests were used to test for 
differences in luciferase activities between static and unidirectional LSS conditions for 
the I-type and D-type promoter constructs under LPS or fluid dynamic conditions, and for 
eNOS protein expression levels among the genotyped HUVECs during the different fluid 
dynamic conditions. In addition, a Student’s t-test was used to test for difference in 
changes in eNOS expression level in response to unidirectional LSS between genotype 
groups.  
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In vivo study data are expressed as the adjusted LS mean ± SEM except for the 
demographic and the biological characteristics. The subject characteristics and in vitro 





Unidirectional laminar shear stress activates translocation of NF-κB p50/p65 in 
HUVECs 
To determine whether the NF-κB complex was activated by unidirectional laminar 
shear stress (LSS) in HUVECs, NF-κB translocation under unidirectional LSS was 
monitored using the MercuryTM Pathway Profiling System (Clontech). In this experiment, 
either pNFkB-TA-luciferase gene (Luc) reporter vector or pTA-Luc control vector was 
co-transfected along with phRL-TK Renilla luciferase control vector followed by 24 
hours of unidirectional LSS stimulation. In the pNFkB-TA-Luc vector, a minimal 
promoter (TA-luc) is under the control of multimerized kB binding sites. Reporter and 
control vectors were introduced into HUVEC cells by lipofection. After 24 hours of LSS, 
cell extracts were assayed for luciferase activity. The NF-κB sites in the pNFkB-TA-Luc 
vector significantly increased activity of the promoter (> 100 fold increase over the 
control vector) under both static and unidirectional LSS conditions (P<0.001). <Figure 3> 
However, no significant difference in the level of reporter gene expression was observed 
between the two fluid dynamic conditions. This result indicated that the NF-κB complex 
is active in human endothelial cells and may be involved in the induction of downstream 
gene expression. However, it was unclear whether unidirectional LSS triggered the 
activation and translocation of NF-κB complex due to the high gene expression levels 
observed in the static condition. Similar high basal activity of the NFkB-TA-Luc vector 
has been observed in other cell types (unpublished results: I.K. Farrance and T.B. 
Rogers) 
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 In order to clarify the involvement of unidirectional LSS in the activation of the NF-
κB complex, we monitored the translocation of the NF-κB subunits, p50/p65, under 
unidirectional LSS by subsequent immunoblot assays. HUVECs were subjected to 
unidirectional LSS for up to 60 minutes and nuclear extracts were prepared for p50/p65 
protein immunoblot assays at the 0, 15, 30, and 60 minute time periods. In this 
experiment, gradual translocation of both p50 and p65 subunits was observed under the 
unidirectional LSS. <Figure 4> This observation was consistent with what we observed 
using the conventional NF-κB activation method using lipopolysaccharide (LPS, 100 ng/ 
µl) stimulation. <Figure 5>  
 
 
Figure 3. Addition of NF-κB binding sites in the pNFkB-TA-Luc vector significantly 
increases activity of the promoter under both static and unidirectional LSS conditions. 
Data represent the results of statistical analysis of fold increase in adjusted luciferase 
activity over the control observed in the 24 hour unidirectional LSS stimulations (mean 
values and SEM, n=3). HUVECs were transfected with MercuryTM Pathway Profiling 
System including plasmid constructs with or without multiple –kB binding sites in the 
enhancer region followed by luciferase reporter gene, expressed by TA-LUC and kB-TA-
LUC, respectively, and the cells were subjected to 24 hour unidirectional LSS. Renilla 





Figure 4. Both p50 and p65 NF-κB subunits are gradually 
translocated under unidirectional LSS in HUVECs.  
Primary cultured HUVECs were subjected to unidirectional LSS 
and the levels of p50 and p65 proteins were measured in the 
nuclear extracts. LSS: Laminar shear stress  
 
 
Figure 5. Translocation of both p50 and p65 NF-κB subunits occurs with sustained LPS 
stimulation in HUVECs.  
Primary cultured HUVECs were stimulated with LPS (100 ng/µl) for different time 
courses and p50, p105, and p65 protein levels were measured in both cytoplasmic (a) and 
nuclear extracts (b). Time expressed in minutes. These figures demonstrat that NF-κB p50 
and p65 subunits located in the cytoplasm was gradually translocated into the nucleus with 
LPS stimulation. p105 protein existed in resting cytoplasm but gradually disappeared in 




The I-type NFKB1 promoter has higher DNA-protein binding activity  
To determine whether the NFKB1 I/D promoter polymorphism affected DNA-
protein binding activity between the polymorphic promoter region and nuclear proteins 
extracted from HUVECs, we conducted the electrophoretic mobility shift assay. 
As mentioned earlier, the NFKB1 I/D polymorphic site is located 94-bp upstream of 
the transcription initiation site of the gene and has either an ATTGATTG (wild, Insertion 
allele (I)) or ATTG (variant, Deletion allele (D)). Therefore, we synthesized six 
oligonucleotide probes having different sequences: (1) insertion allele (I), (2) deletion 
allele (D), (3) size-matched deletion allele which includes a 4-bases of genomic sequence 
(gcgt) at the 5’ end (D1), (4) substitution of the first ATTG with arbitrary sequences (M1), 
(5) substitution of the second ATTG with arbitrary sequences (M2), and (6) a single 
nucleotide substitution of the first thymidine of the second repeat to adenine (ATTG → 
AaTG, M3). The sequences for the oligonucleotide probes are as below: 
 
 
Insertion (I) : TCCCCGACCATTGATTGGGCCCGGC 
Deletion (D) : TCCCCGACCATTGGGCCCGGC 
Deletion variant (D1) : gcgtTCCCCGACCATTGGGCCCGGC 
M1 : TCCCCGACCcagtATTGGGCCCGGC 
M2 : TCCCCGACCATTGcagtGGCCCGGC 
M3 : TCCCCGACCATTGAaTGGGCCCGGC 
 
Using the wild (I), variant (D or D1) or mutant (M1, M2, or M3) 25-base pair 
oligonucleotides representing the polymorphic regions, we found two complexes forming 
between nuclear extracts from unstimulated HUVEC and the probes. A faster mobility 
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complex (marked as *) was deemed non-specific as it was formed with all probes, 
including a κB mutant probe. A second slower mobility complex was also formed. This 
complex was specific as it formed between the I probe but not the κB or mutant κB 
probes. Also, the I probe had higher binding activity compared to the D or the size-
matched D1 probes, and the mutant M2 and M3 probes did not show binding activity. 
<Figure 6a>  
Competition assays, using excess nonradioactive oligonucleotide probes (50 times 
higher concentration), confirmed that the I allele forms the specific complex with higher 
affinity than the D allele (compared I to D and D1 competition). Oligonucleotides with 
the 5’ ATTG (M1) abolished and a single point mutation in the 3’ ATTG competed for 
binding, while an oligonucleotide with the 3’ATTG abolished did not compete. Overall, 
these results showed that a protein(s) present in HUVEC binds to the I/D region of the 
NFKB1 promoter, and preferentially binds to the I allele sequence. <Figure 6b> 
We investigated the uncharacterized transcription factor that binds to the sequence 
using the Transcription Element Search Software on the World Wide Web (TESS 
software, University of Pennsylvania, PA). Promoter sequence analysis revealed that the 
TGATTGG sequence in the polymorphic region of the I allele is in complete homology 









Figure 6. I-type NFKB1 gene promoter has higher protein binding activity.  
Nuclear protein extract was prepared from basal HUVECs. Olgonucleotide probes included 
insertion and deletion alleles and various mutations of the NFKB1 promoter polymorphic 
regions (I:TCCCCGACCATTGATTGGGCCCGGC, D: TCCCCGACCATTGGGCCCGGC, 
D1:gcgtTCCCCGACCATTGGGCCCGGC, M1: TCCC CGACCcagtATTGGGCCCGGC, 
M2: TCCCCGACCATTGcagtGGCCCGGC, M3:T CCCCGACCATTGAaTGGGCCCGG 
C) . a) Protein binding activities of the six NFKB1 promoter mimic oligonucleaotide probes. 
b) Protein binding activity of the I-type NFKB1 gene promoter with competitors using excess 
nonradioactive I-type, D-type, D1, M1, M2, M3 probes (50 times higher concentration). A 
wild consensus or mutant –κB binding sequence was used for a positive control. 3) the I and 
D allele sequence is similar to the AP-1binding element sequence. −: free nuclear protein +: 
nuclear protein added  *: non-specific bands may result from probe-dimers or self-
complementarity due to the GC rich regions at the 3’ franking end of the probes  
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p50/p105 NFKB1 I/D promoter polymorphism regulates NFKB1 gene expression 
To determine whether the NFKB1 I/D polymorphism regulates transcriptional 
activity of the NFKB1 promoter, we conducted reporter gene assays under 
lipopolysaccharide (LPS), oscillatory shear stress (OSS), and unidirectional LSS 
stimulations in HUVECs. In these experiments, the HUVECs were transiently transfected 
with either chimeric NFKB1 I- or D-type promoter-LUC reporter gene plasmid 
constructs 18-24 hour before the stimulation. In addition, basal cytoplasmic p50/p105 
protein levels were measured in II and DD genotyped HUVECs to investigate whether 
the polymorphism affected protein expression levels. 
Based on a previous study91 that demonstrated different promoter activities between 
NFKB1 I and D type promoters in LPS-stimulated HeLa and HT-29 cell lines, the 
transiently transfected HUVECs were subjected to 6 or 24 hours of the LPS (500 ng/µl) 
treatment. Both promoters were activated with the LPS treatment by 25 to 33 fold vs. 
control. The I-type promoter showed significantly higher activity than D-type promoter 
after LPS treatment. <Figure 7a> 
In the shear stress experiments, the results depended on the type of shear stress 
applied. The I- and D-type promoters showed similar basal activities and no significant 
difference under OSS (P=0.239). However, unidirectional LSS induced the D-type 
promoter (1.4-fold, p=0.024) and downregulated the I-type promoter below the level 
observed under static conditions (0.78±0.14 fold vs. I-static). <Figure 7b> In addition, the 
magnitude of the induction was relatively small (range 0.49 – 1.83 folds) compared to the 










Figure 7. I-type NFKB1 promoter has significantly higher activity than the D-type 
promoter after LPS treatment. 
NFKB1 I- or D-type promoter with luciferase reporter gene constructs were transiently 
transfected into HUVECs and the transactivities were investigated under the LPS and three 
different fluid mechanical conditions. a) Data represent the results of statistical analysis of 
fold increase in adjusted luciferase activity over the control (0 hr) observed at the 6 or 24 
hour LPS stimulations. b) Data represent the fold increases in adjusted luciferase activity 
over the control (static) observed in the 24 hour OSS or LSS stimulations. Results from 
three independent experiments were used for each analysis. Data are presented as means 
with error bars representing the SEM. hr, hour; I, insertion; D, deletion; LPS, 
lipopolysaccharide; Static, static fluid mechanical condition; OSS, oscillatory Shear 
Stress; and LSS, Laminar Shear Stress *P <.05 vs. D-type 
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Since the above results suggested that the NFKB1 I/D promoter polymorphism 
affects the NFKB1 promoter activity, we investigated whether the NFKB1 polymorphism 
also affected protein expression levels in HUVECs. To test this, we obtained 17 primary-
cultured HUVECs from different donors and identified II and DD homozygote cells. We 
tested the level of p50-p105 proteins in the different passage of these cells (passages 4th 
to 7th). Higher p50-p105 protein levels were observed in the II homozygote cells 
compared to the DD homozygote cells. <Figure 8> These results showed that HUVECs 
with the I-type promoter had higher protein expression levels of NFKB1 gene products, 
and ultimately, a greater number of copies of the NF-κB complex in the cytoplasm, 
through which signaling transduction for downstream gene expression is likely to be 
facilitated in these cells. 
 
 
Figure 8. II homozygote cells have higher basal p50/p105 protein levels compared to the 
DD homozygote cells. 
Cytoplasmic levels of p105/p50 subunit in HUVECs having either II or DD genotype 
under basal conditions. Actin used as an internal control for equal sample loadings. II: 
insertion/ insertion vs. DD: deletion/deletion.  
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The II homozygote HUVECs are more sensitive to unidirectional LSS with respect 
to eNOS protein expression 
Previous studies have demonstrated that the NF-κB signaling pathway, generally a 
proinflammatory transcription factor, is responsible for upregulation of the eNOS in 
response to LSS.33, 60 Furthermore, we found higher levels of NFKB1 gene products in 
NFKB1 I/I cells than D/D cells. Therefore, we tested whether the NFKB1 promoter 
polymorphism affected the level of eNOS gene expression in HUVECs in response to 
unidirectional LSS.  
The II or DD homozygote HUVECs were subjected to 24 hours of unidirectional 
LSS or static conditions and total cell extracts were prepared. We excluded eNOS -786 
CC homozygote cells for this experiment according to a previous report showing a lack 
of eNOS gene expression in response to LSS in these cells.17 There was no difference in 
basal eNOS level between II or DD homozygote cells. However, there was a greater 
eNOS protein levels in II homozygote cells compared to the DD homozygote cells 
(P=0.058) <Figure 9b> These results suggest that NFKB1 II homozygote cells are more 
responsive to unidirectional LSS in terms of the induction of the eNOS gene expression, 











Figure 9. II homozygote cells are more responsive to unidirectional LSS in terms of the 
induction of eNOS gene expression. 
Primary cultured HUVECs were genotyped for the NFKB1 I/D polymorphism. II and DD 
homozygous were used for the present experiment. The HUVECs were subjected to the 
unidirectinal LSS (15 dyne/cm2) for 24 hours using a cone-plate apparatus; and eNOS protein 
levels were measured in total extracts.  a) An example of immunoblot assay performed for 
eNOS protein levels in the static or 24 hour LSS stimulated II or DD genotyped HUVECs. b) 
Summary of statistical anaylsis (n=6) for eNOS protein levels expressed in fold increase over 
II homozygote cells under static conditions. All eNOS protein levels were adjusted to the 
actin protein levels. LSS, laminar shear stress § P=0.058 vs. DD-LSS (Mean±SEM)  
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The I-allele is associated with higher reactive hyperemic forearm blood flow before 
exercise training 
 
To determine the association of the NFKB1 I/D polymorphism with the adaptability 
of endothelial function in response to exercise training, genotyped Pre- and Stage I- 
hypertensive subjects underwent 6 months of standardized aerobic exercise training, and 
reactive hyperemic FBF measurements were performed before and after the exercise 
training using the venous occlusion plethysmography method. Mean resting FBF was 
calculated from three separate measures. After 5 minutes of upper arm arterial occlusion, 
reactive hyperemic FBF was recorded for 7 cardiac cycles every 15 seconds during the 3 
minute reactive hyperemic period. All data related to the reactive hyperemic FBF were 
adjusted for demographic (age, gender and ethnicity) and biologic (body weight, mean 
BP and BMI) confounding factors. 
Subjects’ general characteristics are shown in Table 1. In our study population, 
genotype frequencies for the NFKB1 I/D promoter polymorphism were 21.4 %, 55.4% 
and 23.2% for II, ID and DD, respectively. These genotype frequencies were similar to 
those observations of previous studies13, 91. The 36 samples used for the final (after 
exercise training) FBF analysis included the 27 subjects who completed baseline (before 




Table 1. Characteristics of the study subjects in the human exercise training intervention study 
 
    before (n=47) after (n=36) Cohort (n=27) 
     
Gender (f/m)  24 / 23 16 / 20 12 / 15 
Ethnicity (w/nw)  24 / 23 18 / 18 13 / 14 
     
Age (yrs)  58.5 ± 0.8 58.7 ± 0.7 58.6 ± 1.3 
Height (cm)  171.0 ± 1.4 170.5 ± 1.3 171.5 ± 2.0 
Weight (kg)  84.4 ± 2.1 84.1 ± 1.9 84.0 ± 2.3 
SBP (mmHg)  132.8 ± 1.6 132.6 ± 1.9 132.7 ± 2.4 
DBP (mmHg)  87.9 ± 0.9 87.1 ± 1.0 87.3 ± 1.3 
MBP (mmHg)  102.7 ± 1.1 102.1 ± 1.2 102.3 ± 1.5 
BMI (kg/m2)  29.0 ± 0.6 28.6 ± 0.7 28.7 ± 0.8 
Vo2max (ml/kg/min)  26.5 ± 0.6 29.8 ± 0.9 30.2 ± 1.1 
     
Baseline FBF (ml/min/100ml) 2.1± 0.1 2.3± 0.2 2.2± 0.2 
Maximum FBF (ml/min/100ml) 9.7 ± 0.6 9.9 ± 0.6 10.4 ± 0.5 
Minimum FVR ((mmHg·ml/min/100ml) 11.8 ± 0.7 10.8 ± 0.7 11.4 ± 0.7 
Total AUC (ml/100ml)  10.2 ± 0.5 10.9 ± 0.8 10.8 ± 0.7 
     
NFKB1 I/D (n, %)  II: 12 (26%) II: 8 (22%) II: 8 (30%) 
  ID: 26 (55%) ID: 23 (64%) ID: 18 (67%) 
  DD: 9 (19%) DD: 5 (14%) DD: 1 (3%) 
          
 
FBF data are adjusted LS mean ± SEM. All the other data are unadjusted mean ± 
SEM except for frequency data. before, before exercise training; after, after 
exercise training; cohort, subgroup used for change values; SBP, systolic blood 
pressure; DBP, diastolic blood pressure; MBP, mean blood pressure; BMI, body 
mass index; Vo2max, maximal oxygen consumption; FBF, forearm blood flow; 
FVR, forearm vascular resistance; AUC, area under curve; f, female; m, male; w, 




Table 2 shows the adjusted LS mean ± SEM values for the resting and reactive 
hyperemia parameters in the NFKB1 I/D genotype groups. Before exercise training, 
resting FBF ranged from 0.84 to 5.61 ml·min-1·100ml-1 (mean 2.06 ml·min-1·100ml-1) in 
all subjects. After cuff deflation, FBF was dramatically increased by 443.1 % in the total 
population (P<0.001). Accordingly, the FVR was significantly decreased by 76.8 % 
during the time when peak reactive hyperemic FBF occurred (P<0.001). Similar response 
patterns were also observed after exercise training. 
There were no age and gender main effects observed in reactive hyperemic FBF 
response before or after exercise training. Before exercise training, there was a tendency 
for a greater reactive hyperemic FBF response in II and ID genotype groups compared to 
the DD genotype group (genotype main effect, P=0.122). <Figure 10a> When the II and 
ID genotype groups were combined into an I-allele carrier group and compared to the 
non-carrier group, a significant genotype main effect was observed (P=0.039), and 
likewise, subsequent post-hoc tests revealed that the total FBF during the first minute of 
reactive hyperemia was significantly higher in the I-allele carrier group (P=0.05). <Figure 
11a> After exercise training, no significant genotype main effect was observed among 
the three genotype groups (P=0.275). <Figure 10b and 11b> 
In our in vitro experiments, the I allele of the NFKB1 I/D promoter polymorphism 
was associated with higher gene expression level as well as higher eNOS expression 
under unidirectional LSS in HUVECs. Therefore, it was hypothesized that the I allele 




Table 2. Summary of reactive hyperemic forearm blood flow before and after exercise training 
 
      NFKB1 -94 ins/del Genotype Group 
      II ID DD 
Resting     
 FBF (ml·min-1·100ml-1)     
  before 1.85±0.24 2.20±0.16 1.91±0.28 
  after 1.84±0.36 2.32±0.20 2.74±0.43 
 FVR (mmHg· ml·min-1·100ml-1)    
  before 61.2±7.40 52.6±4.82 61.4±10.89 
    after 64.3±9.10 49.3±5.04 37.0±10.74 
Reactive Hyperemia     
 Peak FBF (ml·min-1·100ml-1)    
  before 10.3±1.03** 10.2±0.67** 8.5±1.17** 
  after 10.1±1.16** 10.7±0.64** 8.9±1.37** 
 % change in FBF     
  before 524.3±75.8 412.9±49.8 392.2±86.8 
  after 569.9±107.8 413.7±59.7 250.9±127.3 
 Minimum FVR (mmHg· ml·min-1·100ml-1)   
  before 10.7±1.23** 11.5±0.80** 13.2±1.80* 
  after 10.4±1.23** 10.2±0.69** 11.7±1.46** 
 % change in FVR     
  before -80.4±4.63 -74.2±3.01 -75.7±6.81 
  after -79.8±4.13 -77.0±2.29 -65.2±4.87 
 Total AUC (ml·100ml-1)     
  before 11.0±0.98 11.0±0.64 8.7±1.12 
  after 8.9±1.45 11.8±0.80 12.1±1.71 
 Flow debt (ml·100ml-1)     
  before 9.3±1.20 11.0±0.81 9.6±1.42 
  after 9.2±1.80 11.6±1.00 13.7±2.13 
 Excess flow (ml·100ml-1)    
  before 5.89±0.75 5.28±0.49 3.34±0.85 
  after 3.87±1.00 5.35±0.55 4.55±1.18 
 Repayment (%)     
  before 70.6±9.54 54.4±6.39 40.5±10.9 
  after 58.4±13.35 51.1±7.33 36.6±15.5 
 Duration (sec)     
  before 161.7±10.6 147.5±6.9 138.5±12.1 
    after 131.7±12.6 163.9±7.0 139.2±14.9 
 
Data are adjusted LS mean ± SEM. Samples sizes for the genotype groups before and 
after exercise training were II (n=12), ID (n=26), DD (n=9) and II (n=8), ID (n=23), DD 
(n=5), respectively. % change, percent change from resting. FBF, forearm blood flow; 
FVR, forearm vascular resistance; AUC, area under curve. *P ≤ 0.05 **P ≤ 0.01 vs. 






































































Figure 10. Difference in reactive hyperemic FBF response before and after 
exercise training among II, ID and DD genotype groups.  
Data are adjusted LS means with error bars representing SEM. Age, gender, 
ethnicity, weight, mean blood pressure, body mass index were used as covariates. 











































































Figure 11. I-allele carrier group has higher reactive hyperemic FBF response than 
DD homozygote group before and after exercise training.  
Data are adjusted LS means with error bars representing SEM. Age, gender, 
ethnicity, weight, mean blood pressure, body mass index were used as covariates. 
I: insertion, D: deletion.  
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In this analysis, subjects (n=26, 58.7 ± 1.3 yr)  who completed both baseline and 
final FBF testing were used, and only II and ID genotype groups were compared due to 
the small sample size in the DD homozygote group (n=1). Change values were calculated 
for peak FBF, minimum FVR, and total AUC. All data related to the change value were 
adjusted for age, gender, ethnicity, and baseline values (peak FBF, minimum FVR, and 
total AUC values before exercise training). None of the initial subject characteristic 
values in the cohort were significantly different between the genotype groups; and 
VO2max was significantly increased after exercise training in both genotype groups (both 
P<0.001). In the population, peak FBF, minimum FVR, and total AUC were not 
significantly changed after exercise training. No significant differences in the change 
values were observed between the genotype groups. <Table 3> In all subjects, inter-
individual variation in these variables was large such that percent changes in peak FBF, 
minimum FVR, and total AUC ranged from -40.1 to 94.1 %, from -50.7 to 51.74 %, and 
from -55.9 to 150.8 %, respectively. 
 
Table 3. Percent changes in reactive hyperemic forearm blood flow 
reponses after exercise training 
  II ID 
%∆ FBFpeak 7.45 ± 10.05 9.89 ± 6.43 
%∆ FVRmin -2.01 ± 7.88 -6.11  ± 5.07 
%∆ total AUC -5.12 ± 15.05 12.09 ± 9.41 
 
Data are adjusted LS mean ± SEM. For this analysis, II and ID 
genotype groups were compared due to lack of DD homozygote 
subjects (n=1). Samples sizes for the genotype groups were II 
(n=8) and ID (n=18), respectively. %∆, percent change from 
before exercise training; FBFpeak, peak forearm blood flow; 







The endothelial isoform of nitric oxide synthase (eNOS) is a vascular enzyme that 
plays a substantial role in maintaining endothelial function since nitric oxide (NO) plays 
a crucial role in the regulation of vascular tone and the function and structural integrity of 
the vessel wall. Nuclear factor kappa B (NF- κB) is an essential transcription factor in 
eNOS gene expression in the endothelial cell response to laminar shear stress (LSS). 
Recently, a functional promoter polymorphism has been reported in the NFKB1 gene 
which encodes for the p50 and p105 NF- κB isoforms91. However, the functional 
polymorphism has not been tested with respect to eNOS gene expression in endothelial 
cells. Therefore, in this study we investigated the functional significance of the -94 
ATTG insertion (I) / deletion (D) promoter polymorphism in human vascular endothelial 
cells. 
The major findings of the present study were that 1) a protein present in human 
umbilical vein endothelial cells (HUVEC) preferentially binds to the I allele sequence 
compared to the D allele; 2) the I allele had significantly higher promoter activity than 
the D allele; 3) the II homozygote cells had higher p50/p105 NFKB1 protein levels than 
the DD homozygote cells; 4) the II homozygote cells showed a significantly greater 
increase in eNOS protein levels than the DD homozygote cells under unidirectional LSS; 
and 5) the I-allele carrier group had a higher reactive hyperemic FBF response before 
exercise training. However, the NFKB1 I/D polymorphism was not significantly 
associated with differential changes in endothelial function following exercise training. 
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p50/p65 NF-κB complex activation under unidirectional laminar shear stress 
Previous studies showed that shear stress increases nuclear translocation of the NF-
κB, and elevates the transcriptional activity of promoters containing the -κB binding 
element in bovine aortic endothelial cells92, 97, 168. In the present study, we confirmed that 
in HUVECs, the p50/p65 NF-κB complex translocated into the nucleus under a 
physiological level of unidirectional LSS (15 dyne/cm2) generated by a cone-and-plate 
apparatus. This result agrees with previous findings reported by Hay et al. 67 that p50/p65 
NF-κB complex translocation occurred in response to 15 dyne/cm2 of LSS generated by a 
parallel plate flow chamber system incorporated into a closed loop perfusion device.  
Shear-induced NF-κB activation and its role in downstream eNOS gene expression is 
an extensively studied area, and some upstream signaling mechanisms have been 
proposed. Rapid (~5minutes) and transient activation of the inhibitor kappa B kinase 
alpha subunit (IKKα) has been observed in endothelial cells with a similar degree of LSS 
stimulation (12 dyne/cm2) 10 to what we used (15 dyne/cm2) in the present study, and the 
induction of the IKKα was prevented by treatment of c-Src and MEK 1/2 inhibitors 
suggesting that these signaling molecules accounted for upstream IKKα activation33. In 
addition, degradation of the inhibitor kappa B alpha (IkBα) subunit was observed at 30 
minutes of unidirectional LSS. Together, the activation of the NF-κB complex depends 
on the upstream IKKα activation, and consequent dissociation of the IkB complex from 
the NF-κB complex. 
 
Cytoplasmic  p50/p105 protein and eNOS gene expression 
In the present study, the most interesting findings were that the II homozygote cells 
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had higher cytoplasmic p50/p105 protein level than DD homozygote cells, and 
accordingly, that the II homozygote cells demonstrated a greater increase in eNOS 
protein level than DD homozygote cells after 24 hour of unidirectional LSS.  
Several lines of evidence suggest that NF-κB, commonly known as a 
proinflammatory transcription factor, is predominantly responsible for increasing 
transcription of the eNOS gene in response to LSS. In endothelial cells, the activation of 
NF-κB plays a critical role in the intracellular signal transduction induced by flow shear 
stress. Resnick et al.153 identified a cis-acting shear stress responsive element (SSRE, 5’-
GAGACC-3’) in promoter regions of shear responsive genes. Supershift assays using p50 
and 65 antibodies demonstrated that the translocated NF-κB under flow shear stress binds 
to the SSRE in the promoter of the target genes.67 Davis et al.33 identified the SSRE (5’-
GAGACC-3’) at position -990 to -984 base pairs upstream of the transcription start site 
of the eNOS gene and demonstrated that the shear activated p50/p65 NF-κB bound to the 
identified binding sequence. Moreover, Grumbach et al.60 showed that a NF-κB inhibitor, 
Panepoxydone, completely prevented the increase in eNOS mRNA level in endothelial 
cells exposed to the shear stress.  
The present study could not provide direct evidence as to whether or not the higher 
eNOS gene expression in the II homozygote cells was due to the higher basal cytoplasmic 
p50 level. Future studies should determine whether the time course pattern of the nuclear 
translocation of the p50/p65 proteins levels is different between the II and the DD cells 
under LSS. Also, a dose-response study on the effect of the I allele on the p50 protein 
level should be conducted by including the ID heterozygote cells to confirm the current 
finding. 
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We also found that p105 NFKB1 protein level was also affected by the NFKB1 
promoter polymorphism. Whether the upregulation of the p105 protein affected the NF-
κB signaling and the downstream eNOS gene expression is not known. The p105 NF-κB 
protein is considered a member of IκB family because of  the presence of seven ankyrin 
repeats in its C-terminus region154; on the other hand, the p105 protein is considered as a 
precursor protein for p50 protein. It has been demonstrated that the p105 protein is 
constitutively processed via proteasomes, as opposed to degradation, through a 
cotranslational mechanism104. However, the proteolysis of the precursor protein that 
generates p50 is limited by the presence of a glycine-rich region (GRR) between amino 
acids 376 and 404 that serves as a stop signal for proteolysis105, 137. Moreover, multiple 
reports have demonstrated IKKβ-dependent, and IKKα-independent, phosphorylation of 
p105 C-terminal serines including Ser 923 and Ser 927, followed by inducible 
degradation98, 157. However, there is no definitive evidence that this degradation of p105 
has a functional role. Rather, it has been suggested that phosphorylation of the p105 
results in polyubiquitination and degradation of the protein through SCFβ-TrCP binding26.  
With lipopolysaccharide (LPS), a potent activator of NF-κB, we observed that the 
cytosolic p105 protein level was reduced early (~30 minutes) and completely disappeared 
with 60 minutes of treatment. Although it remains controversial whether p105 can also 
undergo inducible processing, the present data supports the notion that external stress (i.e. 
LPS) may trigger post-translational modification and inducible degradation of the p105 
protein.  
 
Protein binding activity and Promoter activity 
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Previous studies demonstrated that the I allele of the NFKB1 promoter showed 
higher protein binding activity and promoter activity than the D allele in immortalized 
cell lines (HT-29: colonic epithelial cells; and  HeLa: cervical cancer cells)91, and a 
significant association has been observed between the D allele and inflammatory bowel 
disease, specifically ulcerative colitis13, 91.  
In the present study, we confirmed the functional properties in primary cultured 
HUVECs. We observed that NFKB1 promoter-reporter gene constructs containing the 
ATTG insertion (I) allele showed significantly increased promoter activity in the primary 
cultured HUVECs following 24 hours of treatment with LPS. We further found that 
nuclear protein extracted from HUVECs preferentially and specifically bound to the 
ATTG (I) containing oligonucleotides. Conversely, the ATTG deletion (D or D1) showed 
weak or non-binding activity to the nuclear proteins. These results suggested that the 
NFKB1 I/D promoter polymorphism may affect promoter activity of the NFKB1 gene; 
and the specific polymorphic region may contain a core binding sequence of an 
unidentified nuclear protein. Future studies should address whether the up-regulation of 
NFKB1 promoter activity observed in I the allele was due to the nuclear protein binding 
to the I-type promoter and weakly to the D-type promoter. 
There was no significant difference in basal promoter activities between I- and D-
type promoters. This result do not agree with our finding that the II homozygote cells had 
higher basal p50/p105 cytoplasmic protein levels compared to the DD homozygote cells. 
A definitive explanation of the discrepancy could not be made by this study since it is 
beyond of its scope. One possible explanation is that the gene expression level was 
regulated by an interaction between a protein binding to the polymorphic site and other 
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transcription factors which bind to a cis-element which is distant from the transcription 
initiation site so that it was not included in the reporter vectors we used for the promoter 
assays. 
Promoter sequence analysis revealed that the TGATTGG sequence in the 
polymorphic region of the I allele is in complete homology with the AP-1 binding site 
previously found in the polyoma virus enhancer122. The AP-1 binding sequence variant 
has yet to be reported in humans. In contrast, the AP-1 binding site was abolished in the 
D allele (ccATTGG). This supported the current findings of a lack of binding activity in 
the D allele sequence. However, this assumption could not explain the presence of 
binding activity in D1 and M1, which showed relatively weak binding. We speculated 
that the binding activity is size dependent (no protein binding occurs when probes were 
21 base pairs or less); or the alteration of the sequence created novel binding sites for 
other nuclear proteins. Additional sequence analysis suggested that D1, 5’-
gcgtTCCCCGACCATTGGGCCCGGC-3’, contains potential binding sites for CCAAT-
binding Protein 1 (CP1); in M1, substitution of 5’ ATTG to cagt created the Sp1 binding 
site (TCCCCGACCc).  
 
Endothelial function and exercise training  
A healthy endothelium serves to (1) inhibit monocyte and platelet adhesion; (2) 
maintain a profibrinolytic and antithrombotic activity; (3) prevent vascular smooth 
muscle cell proliferation; and (4) modulate the vasodilatory response. All these protective 
functions of the endothelium are achieved by the activation of eNOS and ultimately, the 
release of NO. The result of the present study demonstrated that I allele was significantly 
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associated with a higher baseline endothelial function measured by the reactive 
hyperemic FBF response in the Pre or Stage I hypertensive population.  
Because NFKB1 is also a strong candidate gene for numerous inflammatory diseases 
and the risk for immune-mediated conditions, the NFKB1 -94 ATTG I/D polymorphism 
has been studied in several immune diseases such as arthritis14, 115, cancer106, and 
ulcerative colitis13, 91, 136; and an association has been observed in some, but not all, of 
these studies13, 91, 106, 115. However, there is a paucity of association studies on the 
relationship between other vascular disease conditions or risk factors and shear stress 
responsive genes that are regulated by the NF-κB signaling pathways. Therefore, the 
NFKB1 I/D polymorphism should be tested in these cardiovascular pathophysiologic 
conditions, particularly since we have provided evidence that this polymorphism 
modulates the protein expression level of its gene product and the downstream eNOS 
gene expression levels in response to LSS, and appears to be an important risk factor for 
endothelial dysfunction. 
After exercise training, the association between the NFKB1 polymorphism and  
endothelial function was no longer evident. Similar results have been observed in other 
studies135, and this may be due to the downregulation of physiological phenotypes that 
result from the deleterious alleles and due to the other salutary effects of exercise training. 
This notion is conveyed by Dr. Frank Booth who states that “…disruptions in cellular 
homeostasis are diminished in magnitude in physically active individuals compared with 
sedentary individuals due to the natural selection of gene expression that supports the 
physically active lifestyle displayed by our ancestors.”12.  
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Reactive hyperemia refers to the phenomenon of increased blood flow that follows 
relief of ischemia and is a result of extended dilation of conduit arteries and resistance 
arterioles. Several factors have been implicated in the genesis of reactive hyperemia, 
including mechanical15 and neurogenic99 mechanisms, endothelium-derived nitric oxide29, 
40, 121, adenosine15, and membrane-bound ion channels30, 132. Therefore, the measurement 
of reactive hyperemia is not solely endothelium-dependent. However, several infusion 
studies using an eNOS inhibitor (i.e. N-monomethyl-L-arginin, L-NMMA) or a 
pharmacological agonist for eNOS activator (i.e. acetylcholine, Ach) have revealed that 
1) the endothelium-derived NO accounts predominantly for the reactive hyperemic 
vasodilatory response29, 121; and 2) there is a strong correlation observed between the peak 
reactive hyperemic FBF and the acetylcholine induced peak vasodilation (r=0.89, 
P<0.001)73. 
Given the rationale that; 1) flow shear stress in the endothelial cell is increased 
during aerobic exercise; 2) NF-κB plays a crucial role in intracellular signaling 
transduction for  eNOS gene expression in response to flow shear stress; and 3) the 
NFKB1 I/D polymorphism  transcriptionally regulates p50 NFKB1 gene expression, we 
hypothesized that the polymorphism may affect the endothelial function response to 
aerobic exercise training. However, we found that the NFKB1 I/D polymorphism did not 
associate with change values for peak FBF, minimum FVR and total AUC in response to 
aerobic exercise training. The change values after the standardized exercise training were 
highly variable among the individuals, which probably resulted from many other genetic 
and environmental factors. Perhaps this result might also be attributed to the small sample 
size and/or a weaker genetic effect.  
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The ability to detect interactions between genes and environmental factors is 
determined by the precision with which the environmental exposure and phenotype 
variables are measured as well as the magnitude of effect and sample size188. In our 
study, rigorously screened older subjects underwent a dietary stabilization period and a 
highly standardized exercise training program for six months. In addition, the 
interpretation of the FBF measures were performed by two technicians and cross checked 
while blinded to the subjects’ profiles. 
The primary criticism of gene association studies is a lack of reproducibility, 
especially when there is a lack of supporting functional data at the cellular or molecular 
level. It might be suggested that human blood vessels should be used. However, it is an 
inherent limiting factor in human research that resistance blood vessel biopsies are 
difficult to obtain. Moreover, even if they are obtained in studies, the vessels are obtained 
from subjects with significant CV disease where the samples are typically obtained 
during surgical treatment (i.e. angioplasty or coronary artery bypass graft). 
The present approach was considered to be the best way to provide functional data 
for a gene polymorphism related to exercise training-mediated vascular adaptations. Thus, 
the current complementary study design may provide a major breakthrough approach to 
study exercise science and vascular research. Furthermore, this study is an example of a 
translational physiology study in vascular biology and exercise physiology research. 
 
Summary 
The present study identified a significant association between NFKB1 -94 ATTG 
deletion (D) allele and decreased reactive hyperemic FBF response before exercise 
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training, which was consistent with the effect of NFKB1 on downstream eNOS gene 
expression found in the HUVECs. These results have potential clinical implications for 
endothelial dysfunction that are related to the development and progression of 
atherosclerosis and cardiovascular diseases. Since more than 20% of the population is 
homozygous for the D allele, genotyping of this polymorphism may provide an option for 
more effective health management by increasing the diagnostic capacity and improving 
the conventional risk factor profile (i.e. endothelial function) in affected individuals. 
Additionally, our findings provide insight into the molecular mechanisms involved in the 
intracellular signaling transduction process of eNOS gene expression and function of the 




Hypothesis #1: The NFKB1 I/D promoter polymorphism has functional genetic 
properties that respond to in vitro unidirectional LSS in HUVECs.  
Nuclear translocation of p50/p65 NF-κB complex was observed in response to the 
unidirectional LSS. The NFKB1 I/D promoter polymorphism showed functional genetic 
properties that responded to unidirectional LSS such that: 1) NFKB1 promoter-reporter 
gene constructs that contained the ATTG insertion (I) allele showed significantly 
increased promoter activity in the primary cultured HUVECs; 2) accordingly, the nuclear 
protein extracted from HUVECs bound preferentially and specifically to the ATTG (I) 
containing oligonucleotides; 3) the II homozygote cells had higher p50/p105 NFKB1 
protein levels than the DD homozygote cells; and 4) the II homozygote cells showed a 
significantly greater increase in eNOS protein levels than the DD homozygote cells under 
the unidirectional LSS. 
 
Hypothesis #2: The NFKB1 I/D polymorphism is associated with differential changes in 
endothelial function following exercise training. 
Although the I-allele carrier group had higher reactive hyperemic FBF response 
before exercise training, which was consistent with the molecular assay data,  the NFKB1 
I/D polymorphism was not significantly associated with the differential changes in 





Endothelium-Dependent Vasodilation, Nitric Oxide, and Hypertension 
Endothelial dysfunction 
Over the last two decades, vascular endothelial function has been emerged as a 
strong marker for monitoring cardiovascular (CV) health on the basis that impairment of 
the endothelial function is the earliest event in the process of developing atherosclerosis. 
Endothelial dysfunction has been frequently associated with increased levels of all 
common CV risk factors predisposing to atherosclerosis, such as age19, 37, 174, 190, 
obesity170,  post-menopause173, hypertension108, 143-145, 176, hypercholesterolemia16, 28, 69, 
diabetes119, 120, 185, smoking18, 69, and physical inactivity48. Moreover, prognostic 
implication of the endothelial dysfunction was also reported in various diseases states 
such that impaired endothelial function predicts future cardiovascular events (i.e. cardiac 
death, unstable angina, myocardial infarction, coronary bypass grafting, ischemic stroke, 
or peripheral artery revascularization) in the population experiencing coronary artery 
disease62, 68, 161, 171, chest pain129, hypertension148, and noncardiac vascular 
complications55. Besides to be considered as a useful biological marker, studies have 
demonstrated that the impaired endothelial cell function contributes to the manifestation 
of atherogenic lesions, vasoconstriction, vasospasm116, plaque rupture, intimal growth, 
and, in turn, coronary and cerebrovascular events.  
In the presence of the endothelial dysfunction, improvement in the endothelial 
function was observed with various pharmacological treatments, which are generally 
related to lower the CV risk factors, such as lipid-lowering drugs (i.e. statins86), weight-
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control pills (i.e. Orlistat9), anti-hypertensives (i.e. angiotensin converting enzyme 
inhibitor77 or angiotensin II receptor blocker), and hormone replacement therapy75, 158, 
and also was evident with nutritional and behavioral modifications such as weight  loss43, 
159, low-fat diet, supplementary41 or natural antioxidant intake, smoking cessation, and 
physical activity48, 56, 102, 172.  
Independent of reducing CV risk factors, the underlying mechanisms, by which 
those pharmacological and nonparmacological treatments enhanced protective function of 
the endothelium, also include enhancing anti-atherogenic gene expressions and vascular 
redox state, and reducing systemic and local oxidative stress, and, the most importantly, 
increase nitric oxide (NO), a key endothelium-derived relaxing factor. 
 
Endothelial vasodilatory function 
 Endothelial vasodilatory dysfunction presents early in the pathogenesis of vascular 
disease, and contributes to the manifestation of atherogenic lesions, vasospasm, plaque 
rupture, intimal growth, and, in turn, coronary and cerebrovascular events. Moreover, 
forearm endothelial vasodilator dysfunction has been shown to be a marker of future 
cardiovascular events. Thus, a better understanding of the mechanisms responsible for the 
loss in endothelial vasodilator function associated with insulin resistance may lead to new 
targets for therapeutic intervention. 
Reactive hyperemia refers to the phenomenon of increased blood flow that follows 
relief of ischemia and is a result of extended dilation of conduit arteries and resistance 
arterioles. Several factors have been implicated in the genesis of reactive hyperemia, 
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including mechanical15 and neurogenic99 mechanisms, endothelium-derived nitric 
oxide29, 40, 121, adenosine15, and membrane-bound ion channels30, 132.  
Muscle contraction during physical exercise increases local muscle blood flow by 
metabolic vasodilation of feeding and resistance arteries. To determine mechanism 
underlying the immediately increased blood flow, studies used venous occlusion 
plethysmography technique before, immediately after and recovery of a hand grip 
exercise session. Nitric oxide contributes to the resting blood flow (vascular tone)39, 167, 
187 as well as blood flow during recovery period167; however, nitric oxide may not play a 
significant role in the increased exercising muscle blood flow39, 167, 187. 
 
Peripheral Resistance and Blood Pressure regulation 
Pressure required to deliver blood through the circulatory bed is provided by the 
pumping action of the heart and the tone of arteries. This oversimplified mechanism can 
be illustrated by a basic equation: Blood Pressure (BP) = Cardiac Output (CO) X 
Peripheral Resistance (PR). Each of these primary determinants is, in turn, determined by 
exceedingly complex series of factors. Hypertension has been ascribed to abnormality of 
virtually all of the factors which induces increased CO and/or PR. (Kaplan, 2002: 
‘Clinical Hypertension’ textbook) 
The increased CO could logically arise in two ways: either from an increase in fluid 
volume or from an increase in contractility from an overactivity of sympathetic nerve 
system. However, increased CO has been shown only in young patients with secondary 
and does not persist in established hypertension in middle aged to older hypertensives. 
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The typical hemodynamic finding in the established hypertension is an elevated PR and 
normal CO.27 
According to Poiseuille’s law, vascular resistance is positively related to both the 
viscosity of blood and the length of blood vessel, and negatively related to the third 
power of the lumen radius. Because neither viscosity nor length is much, if at all, altered, 
and because small changes in the luminal radius can have a major effect, it is apparent 
that the increase vascular resistance seen in established hypertension reflects changes in 
the caliber of the small resistance arteries and arterioles and ultimately increase PR.46 
Maintenance of primary hypertension is mainly due to decreased lumen size or radius. 
The persistently elevated PR, a hemodynamic hallmark of primary hypertension, may be 
reached through a number of different paths. These may converge into either structural 
hypertrophy of the vessel wall and functional vasoconstriction.  
 
Nitric Oxide 
Nitric Oxide (NO) is the endothelium-derived relaxation factor. In 1980, Furchgott 
and Zawadzki50 showed that the normal relaxing response to acetylcholine in vessels 
constricted by norepinephrine was abolished if the endothelial lining was rubbed off, 
depriving the cells of an endothelial-derived relaxing factor. Seven years later, Palmer et 
al.142 identified the endothelium-derived relaxing factor as NO, now known to be the 
primary endogenous vasodilator.  Nitric oxide is produced in the process convert L-
arginine to L-citruline, which catalyzed by the dioxygenase, NO synthase.140 The 
synthesis of NO is controlled by endothelial NO synthase availability and is induced by 
calcium-mobilizing agents and fluid shear stress.58 The intravascular half-life of NO is 
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approximately 2 msec, but its extravascular half-life is up to 2 sec, depending on tissue 
oxygen concentration.179 Basal NO release is stimulated by several mediators, such as 
acetylcholine, bradykinin, and substance P, and by mechanical stimuli, such as shear 
stress50, 84. NO also has preferred characteristics as a signal messenger: fast, because it is 
not stored in vesicles; short lived, easily permeable through and between cells; and 
economically produced from an abundant and recyclable substrate.111 Basal generation of 
NO keeps the arterial circulation in an actively dilated state.182 When the inhibitor of NO 
synthesis, N-monomethyl-L-arginine, is infused, BP rises.152 Under basal conditions, 
whole-body NO production is diminished in patients with essential hypertension, and 
impaired NO release may play a role in hypertension and atherosclerosis.47 
 
NO bioactivity and Oxidative Stress 
The term oxidative stress implies a state in which cells are exposure to high 
concentrations of oxygen molecule or chemical derivatives of oxygen, called reactive 
oxygen species.  In the normal metabolic process, oxygen undergoes a series of univalent 
reduction leading to producing superoxide anion, hydrogen peroxide and water.  
Reactive Oxygen Species (ROS) plays several important role in cellular level 
including mediating signaling transduction, regulating gene expression, inducing lipid 
peroxidation, and modulating extracellular matrix remodeling.44 The most particular 
importance to hypertension and vascular biology is the interaction between superoxide 
and NO. Because superoxide and NO are radicals that contain unpaired electrons in their 
outer orbits, they can undergo extremely rapid, diffusion-limited radical-radical reactions 
with rates similar to those of superoxide and superoxide dismutases (SODs). These 
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nonenzymatic reactions can be 10,000 times faster than reactions between superoxide and 
common “scavenger” antioxidants such as vitamins A, E, and C.  
A major product of reaction between superoxide and NO is peroxynitrite anion 
(OONO-). Peroxynitrite is a weaker vasodilator compared to NO, and thus this reaction 
markedly impairs the vasodilator capacity of NO. Many of the beneficial effect of NO 
(inhibition of platelet aggregation, vascular smooth muscle cell growth, monocyte 
adhesion, etc.) are lost when OONO- is present. The rapidity of the reactions between 
superoxide and NO, and superoxide and SODs suggests that their interactions could alter 
the amounts or activities of available superoxide, SOD, or NO. Indeed this seems to be 
the case. In the normal vessel, the balance between NO and superoxide favors the net 
production of NO, permits a state of basal vasodilatation, and the maintenance of normal 
BP.66 The critical balance of superoxide and NO is altered in the setting of numerous 
common disease states. These include atherosclerosis, hypertension, diabetes, cigarette 
smoking, and aging. Treatment of vessels or animals with ecSOD markedly improves 
endothelium dependent vascular relaxation.1 Likewise, infusion of antioxidant vitamins 
transiently improves endothelium dependent vasodilatation as has been shown in forearm 
vessels in human subjects with diabetes.180 
The nitric oxide synthases can produce large amount of superoxide when deprived of 
their critical cofactor (tetrahydrobiopterin) or their substrate (L-arginine). In this state, 
referred to as NOS uncoupling, electron flow through the enzyme results in reduction of 
molecular oxygen to form superoxide rather than formation of NO. In aortas of mice with 
DOCA-salt hypertension, superoxide production from NO synthase is markedly increased 
and tetrahydrobiopterin oxidation is evident. In this model, initial production of ROS 
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from the NADPH oxidase leads to oxidation of tetrahydrobiopterin, uncoupling of eNOS, 
decreased NO production and increased superoxide production from endothelial NO 
synthase. Treatment of mice with oral tetrahydrobiopterin reduces vascular superoxide 
production, increases NO production, and blunts the increase in BP. 
 
Endothelial Dysfunction and Hypertension  
Due to its critical role in vasodilation of NO, testing of vasodilatory capacity using 
various methods including plethysmography, brachial artery ultrasound scanning, and 
quantitative coronary angiography combined with infusion of combinations of NO 
stimulant (Acetylcholine) and other dilator without stimulating NO synthesis 
(Nitroprusside) or NO blocker (L-NMMA) is often used to investigate endothelium-
(in)dependent vasodilation.183 Whereas increased pressure responsiveness was examined 
frequently in the past, most recent work has measured the impairment of vasodilation in 
response to reactive hyperemia or NO-mediated forearm vasodilation.107 
Hypertensives have been shown to have an impaired vasodilatory capacity in 
brachial arteries,145 coronary arteries,38 renal circulation,74 and small arteries and 
arterioles.103 For example, the impaired vasodilation was seen in the responses (usually 
measured as forearm blood flow) to NO stimulants (usually acetylcholine) but not to 
endothelium-independent vasodilators such as nitroprusside. The impairment also 
demonstrated by ultrasonography in response to reactive hyperemia.85 The impairment 
may reflect more than just reduced synthesis of NO but is not related to decreased 
availability of particular substrate, L-arginine.145 This evidence for a role of defective 
NO-mediated vasodilation in the pathogenesis of hypertension has been further 
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strengthened by its recognition in the still-normotensive children of hypertensive 
parents.117, 175 Oxidative stress and subsequent breakdown of NO may be responsible for 
much of the endothelial dysfunction of hypertension.65 
 
Endothelial Vasodilatory Function and Exercise Training 
There are several studies showing effects of exercise training on vascular NO 
function in healthy individuals. Studies have typically examined basal release of NO 
inferred from the effects of NOS inhibition and/or NO released in response to agonist 
such as bradykinin, acetylcholine or methacholine. Green et al.59 demonstrated that four 
weeks of handgrip exercise training increased peak vasodilatory capacity after ischemic 
stimulus but vasodilatory responses to methacholine and sodium nitroprusside 
(endothelium-independent vasodilator) was not altered. In contrast, improved NO 
productions, measured by L-NMMA infusion94 and plasma NOx level,112 with 4-8 weeks 
of aerobic exercise training have been shown in young healthy subjects and this effect 
persists during few weeks of detraining. Goto et al.57  tested effects of different intensity 
of exercise training (12 weeks at mild (25%)-, moderate (60%)-, and high (75%)- 
intensity) on FBF and showed that acetylcholine induced FBF was significantly increased 
in the moderate intensity group but not in the mild- or high- intensity groups. Miyachi et 
al.125 reported that blood flow in the ascending aorta during exercise after 8 weeks of 
aerobic training was significantly larger than that found before training. 
The effects of exercise training on endothelial-dependent vasodilation can be 
characterized by that it is a systemic response by increased vascular shear stress as a 
result of elevation in blood flow, heart rate, pulse pressure, and blood viscosity, and that 
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endothelium-dependent dilation may be altered persistently in the period between 
exercise bout and account, at least in part, for the reduced total peripheral resistance and 
BP.93 Furthermore, long-term exercise training enhances the endothelium-dependent 
vasodilation reserve. For example, in athletes,94 the basal NO production was not 
significantly different compared with sedentary individuals, where forearm vascular 
resistance decreased greater after acetylcholine administration.  
Exercise Training has been also shown augment endothelial vasodilatory capacity in 
hypertensive patients. Higashi et al.78 tested endothelial-dependent (reactive hyperemia) 
and endothelial-independent vasodilation (sublingual nitroglycerine) before and after 
12wks of exercise training in patients with mild- to moderate- hypertension. After 12 wks 
of exercise training, maximal FBF response during reactive hyperemia response to 
ischemic stimulus increased where changes in FBF after sublingual nitroglycerin 
administration were similar before and after 12 wks of exercise training. By the same 
research group,76 it has been proven that the effect of exercise training on augmented 
vasodilatory capacity in hypertensive patients was attributed to endothelial-dependent 
vasodilatory mechanism by acetylcholine and L-NMMA infusion study. 
Physical activity reduces morbidity and mortality from cardiovascular diseases114, 139 
although the precise mechanisms responsible for this salutary effect have not been fully 
uncovered. Studies showed that aerobic exercise improves endothelial function at all 
ages, at all stage of cardiovascular disease. Regular physical training improves peripheral 
endothelium-dependent vasodilation in patients with chronic heart failure82 and coronary 
artery disease64.  
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Nuclear Factor kappa B and Signal Transduction 
Nuclear factor kappa B (NF-κB) is a ubiquitous dimeric transcription factor which 
involves in various expressions of genes that related to inflammation, cell adhesion, cell 
division, apoptosis, and stress response. Acute exercise induces NF-κB activation through 
the mitogen-activated protein kinase (MAPK)-mediated signaling pathway including p38 
and extracellular signal-regulated kinase (ERK).33 In endothelial cells, NF-κB pathway is 
involved in transducing an extracellular signal, which associated with mechanical force 
mediated by flow LSS, into nucleus for eNOS gene expression. 
 
NF-κB Transcription Factor Family and Its Activation 
NF-κB involves in intracellular signaling cascade of various gene expressions. NF-
κB family includes p50/NFKB1, p52/NFKB2, p65/RelA, RelB, and c-Rel. In biological 
systems, these family members presents and acts as homo- or hetero-dimers. NF-κB is 
frequently observed as a form of a p50/p65 heterodimer, encoded by the genes NFKB1 
and NFKB2, respectively.20 
In a quiescent cell, NF-κB complex is retained in the cytoplasm by binding to a 
family of protein inhibitor, IκBs.7 The formation of the NF-κB/IκB complex masks a 
critical nuclear localization domain on a conserved N-terminus region of NF-κB proteins, 
called the Rel homology domain, and this prevents translocation of NF-κB dimers into 
the nucleus. The IκB family includes IκBα, IκBβ, IκBε, and Bcl 3. Each subunit contains 
multiple copies of an amino acid sequence known as the ankyrin repeat. 
Once the cell is stimulated by appropriate stimuli, such as cytokines, 
immunoglobulins, UV light, lipopolysaccharide, oxidative stress and other stresses, IκB 
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kinase (IKK) phosphorylates IκB complex at Ser32 and Ser36 on IκBα subunit followed 
by ubiquitination and proteosome-dependent degradation of the IκB complex.2, 6 
Dissociation of IκB from NF-κB results in exposing a nuclear localizing domain of NF-
κB complex so that the NF-κB complex is translocated into nucleus and bind to κB-
binding site of a target gene to initiate gene transcription. Activated NF-κB complex 
translocated into the nucleus and binds DNA at κB-binding motifs such as 5’-
GGGRNNYYCC-3’ or 5’-HGGARNYYCC-3’ (where H is A,C, or T; R is an A or G 
purine; and Y is a C or T pyrimidine).52 Then, the activated NF--κB  is down-regulated 
through multiple mechanisms including the well-characterized feedback pathway 
whereby newly synthesized IκB α protein binds to nuclear NF--κB and exports it out to 
the cytosol.  
 
IκB Kinase: Upstream Signaling Molecule for NF-κB Activation 
In the process of activation of NF-κB complex, IKK plays a critical role so that the 
upstream signaling transduction pathway has been given an increasing attention. IKK 
comprises three subunits: IKKα, IKKβ, and IKKγ. IKKα/IKK1 and IKKβ/IKK2 are 
catalytic, while the third, called IKKγ or NF-κB essential modulator (NEMO) is 
constitutive. IKK1 and IKK2 are substrates for members of the MAP kinase kinase 
kinase family. Both NF-κB inducing kinase (NIK) and MAPK/extracellular signal-
regulated kinase kinase 1 (MEKK1) can activate IKK1 and IKK2 by phosphorylating 
specific serine residues.52, 138 NIK binds to the adaptor protein TNF-receptor-associated 
factor 2 (TRAF2) and preferentially phosphorylates IKK1, while MEKK1 activated 
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IKK2.128 IKKs may be also downstream targets for TAK1, PKB, PKC (ζ and θ), and 
Akt.36, 138  
Ozes et al.138 showed that AKT1 is involved in the activation of NF-κB by TNF-
alpha, following the activation of phosphatidylinositol 3-kinase (PIK3). The Akt1-
induced NFKB1 activation is mediated by phosphorylation of IκBα at threonine 23, 
which can be blocked by dominant-negative NIK. Conversely, NIK-induced activation of 
NFKB1 is mediated by phosphorylation of IKK1 at serine 176, which can be blocked by 
an AKT1 mutant lacking kinase activity. Considering these results, it is indicated that 
both AKT1 and NIK are necessary for the activation of NFKB1 by TNF-alpha through 
phosphorylation of IKK1. Platelet-derived growth factor promotes cellular proliferation 
and inhibits apoptosis. Romashkova156 showed that PDGF activates the 
RAS/PIK3/AKT1/IKK/NFKB1 pathway. In this pathway, NFKB1 induces putative 
antiapoptotic genes. Zhong et al. 192 demonstrated that transcriptionally inactive nuclear 
NFKB in resting cells consists of homodimers of either p65 and p50 complexes with the 
histone deacetylase HDAC1. Only the p50-HDAC1 complexes bound to DNA and 
suppresses NFKB-dependent gene expression in unstimulated cells.  
 
NF-κB, Mechanotransduction and eNOS Gene Expression 
In endothelial cells, activation of NF-κB plays a critical role in the intracellular 
signaling transduction induced by flow shear stress. The term for this process is 
mechanotransduction. LSS stimulates mechanoreceptors on vascular endothelial cell 
membrane and alters the expression levels of several genes related to endothelial 
function. Rensnick et al.153 identified a cis-acting shear stress responsive element (SSRE) 
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in promoter regions of the flow-sensitive PDGF-β chain gene and it was later shown to 
act as a non-consensus binding site for NF-κB 92.  
Hay et al. 67 found that shear stress induces gene transactivation by NF-κB p50/p65 
heterodimer through proteosome-dependent degradation of IκBα and IκBβ1 in endothelial 
cells. Some components of the signaling pathway involved in the activation of NF-κB by 
flow have been identified in bovine aortic endothelial cells. Bhullar et al. 10 showed that 
degradation of IκBs by activated IKKs  are critical steps in the process. The study also 
demonstrated that induction of IKK 1 / 2 activity by shear stress is inhibited by 
pretreating cells with a inhibitor of the αvβ3 integrin, pointing to a role for this integrin in 
the mechanotransduction process.  
Davis et al.33 indicated that LSS increases eNOS gene expression by NF-κB p50/p65 
heterodimer binding to the GAGACC sequence present in the human eNOS promoter. 
This study also showed that exposure of endothelial cells to LSS resulted in IKK 
phosphorylation via MEK1/2 and tyrosine kinase c-Src signaling molecules which are 
upstream of NF-κB activation.32  
Therefore, while NF-κB activation is generally viewed as a pro-inflammatory 
stimulus, these observations indicate that its transient activation by vascular shear stress 
may increase the expression of eNOS, which will increase the bioactivity of NO and 
could convey vasodilatory characteristics. Taken together, NF-κB activation in 
endothelial cells may be an important intracellular step in improving vasodilatory 
capacity with exercise training, by inducing gene expression of eNOS. 
 
NF-κB and Acute Exercise 
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There are several papers providing evidence for an involvement of NF-κB activation 
in exercise stimulated intracellular signaling transduction. Ji et al.89 reported that one 
hour of treadmill running increase NF-κB binding activity and p50 protein content in rat 
muscle nuclear extracts. This study also measured IκB pathway from cytosolic extracts 
and found that IκBα and IKK contents were decreased, whereas phospho- IκBα and 
phospho-IKK contents were increased in exercise group compared to control.  
Ho et al.80 reported that IKK 1 / 2  phosphorylation and NF-κB activity increased in 
muscle tissue throughout the time course (5-60 min) and 1-3 hours following the 
exercise. With the contraction of isolated muscles, additional kinases were activated, 
which include p38 and extracellular-signal regulated protein kinase (ERK). Using 
inhibitor assays, this study also confirmed that p38 and ERK are involved in the upstream 
signaling pathway to activate the NF-κB in muscle after exercise. Although it has been 
clearly demonstrated that fluid shear stress induces NF-κB activation67, none of studies 
are yet to report whether NF-κB is also activated and participated in the signaling cascade 
triggered by exercise in vasculature. 
 
NFKB1 Gene Polymorphisms 
The human NFKB1 gene, localized to 4q23-q24, encodes two proteins, a 105 
kilodalton (kDa) non DNA-binding cytoplasmic molecule (p105) and a 50 kDa DNA-
binding protein (p50) that corresponds to the N terminus of p105 72. Recently, a 
functional promoter polymorphism in the NFKB1 gene that affects NFKB1 transcription 
has been described91. The NFKB1 -94 ATTG insertion (I)/deletion (D) (NFKB1 I/D) 
polymorphism is a common functional promoter polymorphism. The genotype 
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frequencies of the NFKB1 I and the NFKB1 D are 61% and 39%, respectively, in the 
normal population. The polymorphism is located between its transcription factors binding 
sites, AP-1 and κB, in the promoter region. In immune cells, a luciferase reporter gene 
analysis showed that the NFKB1 I allele had a two-fold higher NFKB1 gene promoter 
activity than the NFKB1 D allele91. However, it has not been tested whether the NFKB1 
I/D polymorphism is a functional in endothelial cells.  
 
Laminar Shear Stress and Endothelial Function 
At the cellular level, exercise acts as a physiological stressor that disturbs resting 
homeostasis. Endurance aerobic exercise can be translated into several distinct, but 
integrated stimuli which include oxidative stress, hypoxic stress, and mechanical stress 
through muscle contraction and increased vascular wall shear force. Among them, in the 
vasculature, the exercise stimulus can be defined as endothelial wall shear stress.  
 
Vascular Endothelial Cell 
Most of the various humoral and mechanical factors that control vascular function 
and structure work through the endothelium, the source of a host of mediators that 
maintain a balance of opposing physiologic and pathologic effects. The endothelium is 
the guardian of the vessel wall, providing an antithrombotic non-sticky surface for blood 
flow, synthesizing molecules that regulate vessel tone and diameter, and allowing 
nutrients to pass from the blood to the underlying smooth muscle. 
Vascular endothelial cell, located at the interface between the circulating blood and 
the blood vessel, are exposed to shear stress in any moment resulting form the tangential 
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force exerted by the flowing fluid on the vessel wall. The magnitude and pattern of the 
shear stress acting on endothelial cells depend on blood flow, blood viscosity, and the 
vascular geometry, which varies with the location in the vascular tree.  
Within the vascular tree, there are gradients of shear stress that typically occur near 
vessel bifurcations or branches, in the regions of arterial narrowing or in the areas of 
extreme curvature. These anatomical regions are traditionally known as 
proatherogenic.113 Direct models of the low or oscillatory shear stress regions have 
revealed shear values on the order of +/- 5 dyne/cm2 (1 dyne = 10 µN/cm2) compared 
with greater than 10 dyne/cm2 in the atheroprotective or LSS regions.90 
 
Vascular Shear Stress: Different Patterns 
The magnitude of the shear stress can be estimated by Poiseuille’s law, which states 
that shear force is proportional to blood flow and viscosity, and inversely proportional to 
the third power of the internal radius.  
Endothelial surface of blood vessel is constantly exposed to hemodynamic shear 
stress. Measurements using different methods show that the shear stress ranges from 1 to 
6 dyne/cm2 in the venous system and between 10 and 70 dyne/cm2 in the arterial 
vascular network.113 Within the vascular tree, there are gradients of shear stress that 
typically occur near vessel bifurcations or branches, in the regions of arterial narrowing 
or in the areas of extreme curvature such as carotid bulb. The complex flow pattern is 
associated with low/oscillatory shear stress (+/- 5 dyne/cm2) that exhibit in predilection 
for atherosclerosis lesions. In contrast, the straight parts of the arterial tree, which are 
generally spared from atherosclerosis, blood flow is more laminar (>15 dyne/cm2).90 
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Based on in vitro analysis, under high fluid shear stresses (>15 dyne/cm2) vascular 
endothelial cells enter a quiescent, anti-proliferative, antioxidant, and anti-thrombotic 
state which is reflected by the downregulation of a number of atherogenic factors.113  For 
example, high fluid shear stress results in the downregulation of vascular cell adhesion 
molecule 1 (VCAM-1) upregulation of antioxidant genes (SOD1, SOD2, and GPX-1), 
downregulation of vasoconstrictive factors (ET-1, ACE) and upregulation of vasodilatory 
factors (eNOS and COX-2). In contrast, endothelial cells exposed to low or oscillatory 
shear stress are thought to enter a procoagulant and prothrombotic state. Specifically, 
such condition have been shown to cause the upregulation of ET-1, endothelin converting 
enzyme (ECE), angiotensin converting enzyme (ACE), and PDGF α and β.118 
 
Laminar Shear Stress during Exercise 
A bout of endurance exercise increases heart rate, pulse pressure, and blood flow in 
circulatory system. These changes in systemic hemodynamic components can be 
translated into elevated the pulsatile stretch and shear stress on endothelium. Shear stress 
is a tangential force exerted at a vector that is parallel to the long axis of the vessel (i.e. 
15 dyne/cm2), where pulsatile stretch is fluctuation of arterial pressure acting on 
perpendicular to the longitudinal axis of vessel (i.e. 15±10 dyne/cm2).70 The magnitude of 
shear stress can be modified by typical physiological conditions that affect increase in 
blood flow or flow pulsatility such as reactive hyperemia and exercise. For example, 
during ischemic stimulus-induced reactive hyperemia, peak wall shear stress was up to 40 
dyne/cm2 in brachial arteries.54 During exercise, magnitude of shear stress in large 
conductance arteries are 12 dyne/cm2 (7 dyne/cm2 during rest) and 16 dyne/cm2 (12 
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dyne/cm2 during rest) at the supraceliac level and the infrarenal level, respectively.22 It is 
not surprise result of which the increment is not quiet large in aortas because its naturally 
bigger radius. We can carefully scrutinize that the increased shear stress during a bout of 
exercise in small and resistance arteries may be bigger scale than those numbers even 
taking in count of the capacity of vasodilatory response.  
The effect of exercise in the properties of shear stress can be found not only in the 
magnitude but also in the pattern of flow. Cheng et al.23, 24 showed that, using magnetic 
resonance imaging, that flow and shear oscillations present at rest were eliminated during 
exercise. These result agreed with previous observations of which great reduction in flow 
reversal and retrograde during exercise.127, 147 In addition, Taylor et al.178 measured 
hemodynamic conditions in the abdominal aorta using a three dimensional computer 
model of a healthy human aorta, and concluded that moderate levels of lower limb 
exercise can eliminate the flow reversal and regions of low shear stress that exist under 
resting conditions. 
 
Laminar Shear Stress and Mechanotransduction 
The ways by which shear stress is translated into various endothelial responses 
involved multiple mediators. The shear stress has short- and long- term effects on 
vascular tone through various pathways including ion-channel and receptor mediated 
signal transduction. The mechanosensors on the endothelium that sense changes in shear 
stress are poorly defined at the molecular level, but at the cellular level a timescale of 
cell-signaling pathways has been carefully described. The endothelium response to shear 
stress probably achieved by calcium influx. These changes in intracellular calcium 
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concentration drive changes in potassium channel activation, the generation of inositol 
triphosphate and changes in G-protein activation to inform the cellsignaling cascade 
within endothelial cell. These signaling cascades within the endothelial cell are activated 
within a period of several minutes up to one hour and include activation of the mitogen-
activated protein kinase (MAP kinase) signaling cascade and the translocation of the 
nuclear factor – kappa B (NF-κB) from the cytosol in to the nucleus. These signal 
transduction cascade induce downstream gene expression.87  
Some of these gene have a particular consensus of nucleotides in the 5’ region of the 
gene, which is known as the shear stress responsive element (SSRE). Mutation of this 
limited cassette of bases can result in the loss of sensitivity of gene expression in 
response to shear stress. The mechanism by which flow augments the expression of 
eNOS involves SSRE within the promoter region of the gene. The consensus sequence 
for the SSRE in the eNOS promoter is GAGACC, a putative transcription factor binding 
site that is common to the promoter regions of many endothelial genes that are responsive 
to shear stress including tissue factor, intercellular adhesion molecule (ICAM), 
Transforming growth factor - beta1(TGF-β), platelet derived growth factor – beta(PDGF-
β), and endothelin-1(ET-1).153 
 
eNOS gene expression and Exercise Training 
A number of studies support the hypothesis that increases in blood flow associated 
with each bout of exercise generate a shear stress signal for vascular adaptation. Long-
term changes in flow (like an exercise) exert their effects on endothelium-dependent 
vasodilation by modulating the expression of eNOS. The expression of mRNA for eNOS 
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synthase is unregulated in cultured endothelial cells exposed to LSS.34, 189 Similarly, the 
magnitude and nature of shear stress have a major impact on endothelial cell NOS gene 
expression. Noris et al.133, in cultured HUVECs, demonstrated that LSS dose dependently 
up-regulate eNOS gene expression, showing that turbulent shear stress has no effect on 
the NOS expression. 
Delp et al.34 demonstrated that increases in blood flow caused by exercise increased 
eNOS protein contents and endothelium-dependent vasodilation. 
Laughlin et al.101 showed that exercise training induce increase eNOS protein level in 
non-uniform manner throughout the coronary artery in pig. The increase was observed in 
small artery (300-1000 µm), in resistance artery (150-300 µm), and all sizes of arterioles 
(large: 100-150 µm; intermediate: 50-100 µm; and small: >50 µm) but not in conduit 
artery (2-3 mm). This result supports their previous findings which exercise training 
improved endothelium dependent vasodilatory capacity in small artery but not in conduit 
artery.  
 
Genetics in Endothelial Vasodilatory Function 
Heritability in Endothelium Dependent Vasodilation 
Benjamin et al.8 estimate heritability of flow mediated dilation from the Framingham 
Offspring Study. In the study, endothelial vasodilatory function was measured by the 
flow mediated vasodilation during reactive hyperemia using a ultrasound in 2883 
Framingham Heart Study participants. Arterial blood flow was interrupted for 5 minutes 
by cuff placed on the proximal forearm by inflating up to 200 mm Hg or 50 mm Hg 
above individual systolic BP. Percent and actual flow mediated dilation (%FMD and 
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FMD) were assessed between 55 and 65 seconds after cuff deflation. The study showed 
that the heritability of FMD was 12% to 14% suggesting the modest contribution of 
genetic factors to the variability in endothelial vasodilatory function.  
Even though only one study is available to date for the estimated heritability of 
endothelial vasodilatory function, genetic contribution to endothelial vasodilatory 
function has been supported by earlier studies demonstrating that young individuals with 
a family history of CVD have diminished endothelial function.  
Clarkson et al.25 studied endothelial vasodilatory function in 50 offspring of patients 
with premature coronary artery disease (CAD). FMD was measured by brachial artery 
diameter using ultrasound in response to reactive hyperemia, and to sublingual 
nitroglycerine. In the family history group, FMD during reactive hyperemia was impaired 
whereas FMD after nitroglycerine administration was comparable with control groups. 
These result suggested that reduced FMD was due to endothelial dysfunction.  
Schachinger et al.160 tested coronary blood flow response to acetylcholine 
(endothelial- dependent) and to papaverine or adenosine (endothelial-independent) in 150 
patients having chest pain or PTCA of single vessel disease. The study demonstrated that 
coronary blood flow responses to acethylcholine were reduced in a dose-dependent 
manner in patients with a positive family history. Also, it is evident by multivariate 
analysis that the positive family history was a predictor of coronary blood flow increase 
to acetylcholine along with hypercholesterolemia and age.  
A study from Gaeta et al.,51 investigated whether changes in brachial-artery 
reactivity measured by FMD during reactive hyperemia are present in adolescents and 
young adults with a parental history of premature myocardial infarction. In this study, 80 
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healthy young offspring of parents with(n=40) and without(n=40) a history of premature 
myocardial infarction underwent the measurement of the brachial-artery vasodilatory 
response after 4.5 minutes of arterial occlusion. The group of offspring of parents with 
premature myocardial infarction had lower FMD than the control groups.  
 
Gene Association Studies and Endothelial Vasodilatory Function 
 According to the Pub-Med search results, 17 articles, to date, have been 
published, which investigating associations of specific gene polymorphism with 
endothelial vasodilatory function. The studies included 12 polymorphisms from 10 
candidate genes. The genes tested for the association were endothelial nitric oxide 
synthase(eNOS)95, 181, angiotensin converting enzyme(ACE),4, 146 
angiotensinogen(AGT)96, angiotensin II receptor type 1(AT1R)96, aldosterone synthase 
(Cyp11B2), G-protein β3(GNB3)124, neuropeptide Y(NPY)88, β2-adrenergic receptor 
(β2AR)81, p22phox and paraoxonase-1 (PON1)177 genes. Among the 12 polymorphisms, 
7 polymorphisms have been reported to be associated with a measurement of endothelial 
vasodilatory function. The associated polymorphisms include eNOS 4a/b, ACE I/D, AGT 
T174M, AT1R A1166C, NPY Leu7Pro, β2AR Gly16Arg and PON1 Q192R. In contrast, 
3 polymorphisms in each of eNOS, AGT, and CYP11B2 genes have been shown no 
associations with the endothelial function, whereas 2 polymorphisms, GNB3 C825T and 
p22phox C242T, have been demonstrated inconsistent results.  
 In the studies, endothelial vasodilatory functions were measured mostly in the 
brachial arteries. However, some of the studies measured the vasodilatation in hand 
veins, lower limb, or coronary arteries. Lack of a uniformed standard method to measure 
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the endothelial vasodilatory function can be a problem to integrate the results from 
different studies. To measure endothelium-dependent vasodilation, flow mediated 
dilation during reactive hyperemia and intravenous infusion of acetylcholine are most 
frequently used methods, where, in some other studies, bradykinin, metacholine, calcium 
ionophore, paraverine, and adenosine were used. For endothelium-independent 
vasodilation, nitroglycerine (NTG) or sodium nitroprusside (SNP), and glyceryl trinitrate 
(GTN) were used.  
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1. Subjects were participants in a large exercise intervention study, the Gene Exercise 
Research Study, which investigate the genetic influence on changes in BP with 
endurance exercise training. 
2. Subjects were sedentary (aerobic exercise <2 times/wk, <20 min/session, sedentary 
job); 50 - 75 yrs of age; nonsmoker, nondiabetic; not on lipid-lowering medications; 
and no evidence of chronic obstructive pulmonary disease. 
3. Subjects had Pre or Stage I Hypertension (systolic BP: 120-159; diastolic BP: 80-99 
without medication) 
4. Subjects were recruited from the Washington D.C. metropolitan area surrounding the 
University of Maryland, College Park, MD through advertisements and public service 
announcements. 
5. Endothelial function was measured by venous occlusion plethysmography method 
during reactive hyperemia. 
6. All women were postmenopausal for more than past 2 years. Those who were using or 
not using hormone replacement therapy (HRT status) were instructed to continue their 
HRT status throughout the study period.  
7. Human Umbilical Vein Endothelial Cells were obtained from the Emory Skin Diseases 
Research Center, Department of Dermatology, Emory University School of Medicine 
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8. Unidirectional shear stress experiment was conducted at the Vascular Mechanics 
Laboratory, Department of Cardiology, Emory University School of Medicine using 




1. The concept that one gene will contribute substantially to changes in vasodilatory 
capacity response to exercise training was an oversimplification. However, the 
rationale for selecting the candidate gene was (1) both exercise and LSS activate NF-
κB, (2) both exercise training and LSS induce eNOS gene expression, (3) NF-κB 
pathway is important to induce the eNOS gene expression inresponse to LSS, and (4) 
there is strong evidence that the NFKB1 I/D promoter polymorphism transcriptionally 
regulates the NF-κB level.  
2. Exercise training produced other stimuli on endothelial cells and improves endothelial 
function through other mechanisms. This study focused on LSS as an important 
stimulus on endothelial cells during exercise.  
3. Specific aim 1.4. (Determine whether the NFKB1 I/D promoter polymorphism affects 
intracellular levels of eNOS protein under unidirectional LSS in HUVECs) was 
addressed by using HUVECs with different genotypes (II and DD). 17 HUVEC cell 
lines from different people were genotyped to collect for HUVECs with the specific 
genotypes. It assumed that the collected HUVEC cells were not identical related to 
their other genetic factors. However, the HUVECs were also genotyped for a recently 
reported functional eNOS polymorphism (eNOS T-786C) to prevent possible 
confounding effects of the polymorphism on current findings. Although genetically 
identical human endothelial cell line are commercially available, using primary 
cultured HUVECs met the aim of the current study design of comparing HUVECs 
with different genotypes. 
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4. The present study did not include a control group. For subjects who fall into the Stage 
1 Hypertension categories, lifestyle modifications, including increasing physical 
activity, were recommended (JNC VII). The recommendation for physical activity was 
at least 30 min per day, most days of the week. Subjects in the present study 
underwent a 6 mo exercise training intervention. Since there was no possible 
alternative treatment as part of this study, then to include a hypertensive group and not 
treat them would have been unethical. 
5. Mixed ethnic population was used to improve a statistical power in this study. 
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APPENDIX B – Definition of terms 
 
Endurance aerobic exercise training: A systemic physical conditioning designed to 
enhance circulatory and respiratory efficiency that involves vigorous sustained 
exercise.  
Signal transduction: The cascade of processes by which an extracellular signal interacts 
with a receptor at the cell surface, causing a change in the level of a second 
messenger and ultimately effects a change in the cell's functioning (for example, 
inducing gene expression). 
Mechanotransduction: The process by which cells convert mechanical stimuli into a 
chemical response. It can occur in both cells specialized for sensing mechanical cues 
such as mechanoreceptors, and in parenchymal cells whose primary function is not 
mechanosensory. 
Genetic polymorphism: The occurrence in a population (or among populations) of 
several phenotypic forms associated with alleles of one gene or homologs of one 
chromosome. 
Genome: The entire genetic content contained in a haploid set of chromosomes in 
eukaryotes 
Gene polymorphism: A DNA sequence variation, occurring when a single or a set of 
nucleotides in the genome is altered. A variation must occur in at least 1% of the 
population to be considered a common gene polymorphism.  
The insertion/deletion polymorphism: A gene polymorphism that arises by insertion or 
deletion of one or more nucleotides into a DNA sequence. 
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Endothelium: The endothelium is the layer of thin, flat cells, that lines the interior 
surface of blood vessels, forming an interface between circulating blood in the lumen 
and the rest of the vessel wall. Endothelial cells, a type of epithelial cells, line the 
entire circulatory system, from the heart to the smallest capillary. 
Shear stress: The components of stress at a point that act parallel to the plane in which 
they lie. In the vascular system, shear stress refers to a tangential force exerted at a 
vector that is parallel to the long axis of the vessel. 
Laminar shear stress: The shear stress induced by laminar flow which is nonturbulent 
flow of a viscous fluid in layers near a boundary. 
Flow shear stress: The blood flow-mediated friction force acting on the interface 
between the circulating blood and the endothelium of the vessel wall. In the vessel 
tree, flow shear stress exists in exceedingly complex manner with combination of 
laminar and oscillatory shear stress which are mediated by laminar and turbulent 
flow, respectively. 
Unidirectional laminar shear stress: The laminar shear stress continuously exerted one 
direction only. This type of shear stress can be simulated in an in vitro system using 
cone-and-plate apparatus.  
Dyne: The unit to express a level of shear stress. A centimeter-gram-second unit of force, 
equal to the force required to impart an acceleration of one centimeter per second per 
second to a mass of one gram. (1 dyne = 10 µN/cm2) 
Endothelial function: Broadly, the function of endothelium in vascular tone regulation, 
immune cell filtration, angiogenesis and preventing atherosclerosis. Endothelial 
dysfunction, or the loss of proper endothelial function, is a hallmark for vascular 
 84
diseases, and often leads to atherosclerosis. In vascular biology, endothelial function 
often refers to the endothelium-dependent vasodilatory function which is mediated 
by nitric oxide production and its bioactivity. Forearm blood flow and flow-mediated 
dilation measured by plethysmography and ultrasound during reactive hyperemia are 
widely used to measure the endothelial function. 
Reactive hyperemia: Hyperemia after a transient ischemic period.  
Signal profiling: Monitoring the binding of transcription factors to enhance elements and 
screen for the induction of key signaling pathways. 
Protein expression: The process by which a gene's information is converted into the 
protein structures.  
Promoter: A DNA molecule to which RNA polymerase and other transcription factors 
bind, initiating a gene to be transcribed 
Transient transfection: Temporary introducing recombinant DNA into eukaryotic cells, 
such as endothelial cells. 
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